Visual disturbances and blindness

H7_VISUALDISTBLIND

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H53-H54 Cause of death: ICD-10 — H53-H54 2 out of 7 registries used, show all original rules.	31014
4. Check minimum number of events None	31014
5. Include endpoints H7_VISUDISTURB H7_BLINDANDVISIMPAIRMENT	31498
6. Filter based on genotype QC (FinnGen only)	28442

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	H7_VISUALDISTBLIND
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_VISUDISTURB\|H7_BLINDANDVISIMPAIRMENT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H5[3-4]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H5[3-4]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Visual disturbances and blindness based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	28442	17418	11024
Unadjusted period prevalence (%)	5.75	6.18	5.05
Median age at first event (years)	60.02	57.81	63.50

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
29445: Matched controls
294100

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

322.8

4643

26096

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

12.2

320.4

320

265

H50.2

ICD-10 Finland

Vertical strabismus

8.1

317.3

429

538

F29

ICPC

Eye symptom/complaint other

2.1

313.9

3558

18390

N03AX12

ATC

[U] gabapentin; oral

1.9

308.4

4818

27780

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.1

307.7

970

2432

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

118.0

307.7

1321

117

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.7

307.7

5243

16335

H53.8

ICD-10 Finland

Other visual disturbances

16.4

307.7

1343

856

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.9

307.7

1634

4317

H47.2

ICD-10 Finland

Optic atrophy

14.2

307.7

324

230

H54.7

ICD-10 Finland

Unspecified visual loss

18.4

307.7

707

393

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

13.0

307.7

393

305

R06.0

ICD-10 Finland

Dyspnoea

1.7

307.7

8292

54548

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

307.7

3133

14407

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.1

307.7

4566

23490

R53

ICD-10 Finland

Malaise and fatigue

1.7

307.7

7957

52228

G45.3

ICD-10 Finland

Amaurosis fugax

8.1

307.7

1255

1603

H54.5

ICD-10 Finland

Severe visual impairment, monocular

16.7

307.7

462

280

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

307.7

13303

92504

G44.2

ICD-10 Finland

Tension-type headache

2.1

307.7

4647

24019

H53.2

ICD-10 Finland

Diplopia

138.1

307.7

6158

562

H46

ICD-10 Finland

Optic neuritis

10.2

307.7

556

553

H50.0

ICD-10 Finland

Convergent concomitant strabismus

9.1

307.7

454

503

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

10.7

307.7

600

570

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.7

307.7

1944

7576

H53.9

ICD-10 Finland

Visual disturbance, unspecified

21.3

307.7

4900

2732

H53.3

ICD-10 Finland

Other disorders of binocular vision

38.7

307.7

600

158

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.5

307.7

4467

14223

H53.0

ICD-10 Finland

Amblyopia ex anopsia

108.6

307.7

1468

142

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

307.7

4165

20292

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.6

307.7

3659

14962

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

307.7

2822

10565

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

307.7

11197

79570

H53.1

ICD-10 Finland

Subjective visual disturbances

65.0

307.7

13448

3753

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

13.7

307.7

637

473

TAB00

NOMESCO Finland

Lumbar puncture

3.4

307.7

1772

5507

H50.52

ICD-10 Finland

Exophoria

6.0

307.7

604

1017

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

307.7

15264

104300

XCK00

NOMESCO Finland

Perimetry

5.5

307.7

3802

7666

B01AC04

ATC

clopidogrel; oral

2.1

307.7

5164

27168

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.0

307.7

1823

4722

A02BC02

ATC

pantoprazole; systemic

1.7

307.7

19924

163579

M79.6

ICD-10 Finland

Pain in limb

1.6

307.7

13203

98051

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

307.7

1543

5290

F05

ICPC

Visual disturbance other

5.5

307.7

1942

3729

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.2

307.7

8127

31546

AA1AD

NOMESCO Finland

CT of head and brain

3.2

307.7

12560

55143

R42

ICD-10 Finland

Dizziness and giddiness

2.2

307.7

8449

45629

R51.80

ICD-10 Finland

Headache

2.7

307.7

6444

27775

H54.1

ICD-10 Finland

Severe visual impairment, binocular

80.5

307.7

224

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

307.7

2631

10854

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

307.7

3285

12946

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.0

307.7

1518

3899

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.4

307.7

1483

3502

H53.4

ICD-10 Finland

Visual field defects

171.7

307.7

3806

254

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.4

307.7

4410

14440

CS494

NOMESCO Finland

Other visual field testing

4.8

307.7

1278

2730

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.6

307.7

2002

5904

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.2

307.7

3401

11416

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.4

307.7

3207

10139

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.7

307.7

4076

12323

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.7

307.7

3599

14366

PA6AD

NOMESCO Finland

CT of neck arteries

4.2

307.7

1795

4428

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

307.7

8779

56173

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.6

307.7

2984

8942

H54.4

ICD-10 Finland

Blindness, monocular

78.9

307.7

382

G35

ICD-10 Finland

Multiple sclerosis

4.8

305.3

693

1456

N03AX16

ATC

[U] pregabalin

1.7

304.6

6708

42819

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

7.7

302.0

423

553

H53.5

ICD-10 Finland

Colour vision deficiencies

43.1

301.9

180

N17

ICPC

Vertigo/dizziness

1.9

299.5

4196

23329

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.2

293.2

795

1923

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

290.5

8487

58238

H57.1

ICD-10 Finland

Ocular pain

2.9

289.8

1444

5159

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.6

286.3

966

2728

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

276.9

2020

8710

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

16.3

268.6

227

140

CE2W4

NOMESCO Finland

Eye movement mapping

24.7

265.6

187

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

263.7

5331

33047

C07AB07

ATC

bisoprolol; oral

1.5

262.8

13479

104613

H50.1

ICD-10 Finland

Divergent concomitant strabismus

7.1

262.0

396

564

N02AX02

ATC

tramadol; systemic, rectal

1.5

262.0

12083

91632

N01

ICPC

Headache

1.9

259.8

3676

20434

109

Kela drug reimbursment

Multiple sclerosis

5.4

258.6

511

951

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

258.5

6748

44773

L17

ICPC

Foot/toe symptom/complaint

1.6

257.2

9147

65390

Z3231

NOMESCO Finland

Registered nurse

1.6

257.1

7819

53869

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

2.4

256.5

1849

7922

M54.5

ICD-10 Finland

Low back pain

1.5

252.8

10566

78247

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

13.2

252.7

240

183

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

5.9

250.3

457

790

C10AA05

ATC

atorvastatin; oral

1.5

248.3

11580

87712

37720

ICD-8 Finland

Other diseases of retina and optic nerve, Amblyopia

+∞

247.1

237

N06AX11

ATC

mirtazapine; oral

1.5

246.6

9791

71591

A02BC05

ATC

esomeprazole; systemic

1.5

246.5

11362

85805

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

246.3

2583

12909

WX140

NOMESCO Finland

Parabulbar anesthesy

2.6

244.5

1524

6098

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

243.3

8811

63070

H26.4

ICD-10 Finland

After-cataract

2.0

241.5

3111

16731

N03AX09

ATC

lamotrigine; oral

2.5

241.4

1549

6284

N02BE01

ATC

paracetamol; systemic, rectal

1.8

241.1

25927

235433

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

238.3

1969

8946

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

5.9

237.9

427

726

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

233.2

5320

33957

H02AB06

ATC

prednisolone; systemic

1.5

232.6

13386

105432

H53

ICD-10 Finland

Visual disturbances

5.7

231.4

433

766

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

229.0

2862

15218

R02

ICPC

Shortness of breath/dyspnoea

1.8

227.1

4190

25197

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

224.7

6876

47177

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

223.9

2233

10933

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.3

222.7

853

2611

A04

ICPC

Weakness/tiredness general

1.7

219.1

4942

31392

H51.1

ICD-10 Finland

Convergence insufficiency and excess

11.5

218.9

226

197

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

218.9

2597

13551

XCH00

NOMESCO Finland

Eye pressure measurement

2.4

218.9

1563

6658

R03AC02

ATC

salbutamol; inhalant

1.5

218.7

15471

126319

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.1

217.2

601

1475

S18

ICPC

Laceration/cut

1.5

216.7

13263

105211

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

214.6

5322

34629

H50.31

ICD-10 Finland

Intermittent exotropia

5.7

213.6

400

708

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

213.5

6490

44375

ZXA10

NOMESCO Finland

Bilateral

1.7

213.4

5216

33807

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.2

213.0

868

2759

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

212.5

3661

21546

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.4

211.1

1544

6645

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

206.3

4057

24788

L03

ICPC

Low back symptom/complaint

1.5

205.6

8384

61107

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

205.4

11735

91532

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

6.6

204.1

330

505

L01

ICPC

Neck symptom/complaint

1.7

204.1

4785

30645

H50.30

ICD-10 Finland

Intermittent esotropy

8.2

201.9

267

326

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

201.8

9054

67251

R07.3

ICD-10 Finland

Other chest pain

1.9

200.7

3065

17367

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.9

200.5

595

1536

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

199.5

6209

42590

J01DB01

ATC

cefalexin; oral

1.6

198.4

23630

211935

M25.5

ICD-10 Finland

Pain in joint

1.5

197.5

9142

68267

L28

ICPC

Limited function/disability (L)

1.6

197.4

5434

36193

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

195.7

3600

21558

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

190.9

7344

52710

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.6

190.3

1164

4606

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

190.2

4510

28916

A11

ICPC

Chest pain NOS

1.9

189.3

2585

14117

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

189.1

1643

7603

H54.0

ICD-10 Finland

Blindness, binocular

217.8

188.5

195

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

188.2

20200

176008

N06AX21

ATC

duloxetine; oral

1.8

187.3

3412

20358

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.9

186.6

895

3123

A01

ICPC

Pain general/multiple sites

1.8

186.5

3048

17611

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

186.0

11822

93524

S06.0

ICD-10 Finland

Concussion

1.8

185.9

3191

18710

Z71.8

ICD-10 Finland

Other specified counselling

1.5

185.1

9712

74100

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

184.0

6993

49991

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

183.3

15126

125296

M03BX02

ATC

tizanidine; oral

1.4

183.0

16760

141422

M79.1

ICD-10 Finland

Myalgia

1.7

182.9

4263

27184

R4120

NOMESCO Finland

Occupational therapy

2.1

181.6

1923

9607

R52.9

ICD-10 Finland

Pain, unspecified

1.8

180.6

3103

18188

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

180.5

4573

29774

CKC12

NOMESCO Finland

Photocoagulation of retina

2.4

180.2

1272

5381

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

178.9

3920

24587

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.0

178.8

795

2658

C07AA05

ATC

propranolol; systemic

1.6

177.9

5464

37233

N05BA04

ATC

oxazepam; oral

1.5

176.9

7211

52237

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

176.4

4937

32913

N03AG01

ATC

valproic acid; systemic, rectal

2.1

175.3

1707

8259

D01

ICPC

Abdominal pain/cramps general

1.7

175.2

3706

23017

WX002

NOMESCO Finland

Sedation and analgesia

1.6

174.7

5137

34636

R13

ICD-10 Finland

Dysphagia

2.0

174.0

2048

10624

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

5.9

173.9

314

537

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

172.7

20110

176201

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

172.3

2977

17464

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

7.2

172.3

255

355

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

172.0

8712

65808

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

171.6

9234

70539

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

171.0

8094

60333

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

169.9

11769

94058

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

8.7

169.3

214

247

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

5.9

169.2

306

524

H50.51

ICD-10 Finland

Esophoria

7.6

167.7

237

313

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

166.4

1517

7150

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.7

165.6

906

3389

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

165.1

5012

33989

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

6.9

165.1

255

372

N06AX16

ATC

venlafaxine; oral

1.7

165.0

3854

24534

XF404

NOMESCO Finland

Ambulatory ECG

1.9

164.2

2389

13290

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

163.7

10687

84360

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

163.7

5182

35470

R4110

NOMESCO Finland

Physiotherapy

1.5

163.6

7497

55438

J01AA02

ATC

doxycycline; systemic

1.4

163.5

21265

188973

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

162.8

3866

24706

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

162.2

3646

22974

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

162.1

2857

16843

H52.0

ICD-10 Finland

Hypermetropia

3.0

161.6

714

2378

UJF32

NOMESCO Finland

Coloscopy

1.5

161.4

7043

51558

L12

ICPC

Hand/finger symptom/complaint

1.6

161.0

4929

33471

H52.2

ICD-10 Finland

Astigmatism

3.2

160.5

643

2021

R55

ICD-10 Finland

Syncope and collapse

1.7

160.2

3133

19017

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

159.2

5744

40426

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

159.1

1047

4286

N02BF01

ATC

gabapentin; oral

1.7

158.6

2956

17699

A28

ICPC

Limited function/disability NOS

1.6

158.5

4870

33082

A02BC03

ATC

lansoprazole; oral

1.5

157.1

7452

55392

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

156.7

6261

44984

S01ED51

ATC

timolol, combinations; ophthalmic

1.9

156.3

2114

11481

Z2221

NOMESCO Finland

Medical doctor

1.5

155.9

7258

53741

H34.1

ICD-10 Finland

Central retinal artery occlusion

6.4

155.7

258

405

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

155.7

7168

52955

B01AA03

ATC

warfarin; systemic

1.6

155.7

4726

32004

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

2.3

155.4

1268

5708

H34.2

ICD-10 Finland

Other retinal artery occlusions

6.4

154.9

257

404

S01EC01

ATC

acetazolamide; systemic

3.0

154.3

715

2446

N03AF02

ATC

oxcarbazepine; oral

2.5

154.0

993

4026

R51

ICD-10 Finland

Headache

2.0

153.9

1685

8506

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

153.4

12439

101526

S29

ICPC

Skin symptom/complaint other

1.5

152.7

5787

41097

Z3226

NOMESCO Finland

Physiotherapist

1.6

152.3

4779

32588

Z2445

NOMESCO Finland

Psychologist

2.3

152.3

1156

5046

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

152.0

13720

113904

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

151.4

3535

22463

R05

ICPC

Cough

1.5

151.3

7009

51796

D06

ICPC

Abdominal pain localized other

1.8

151.1

2679

15803

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

151.1

3427

21616

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

8.4

150.8

197

237

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

149.4

3545

22612

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

148.8

5181

36119

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

8.0

147.9

200

251

N03AX14

ATC

levetiracetam; systemic

2.6

147.4

902

3566

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

145.5

2708

16187

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.1

145.4

400

977

ZXA05

NOMESCO Finland

Left side

1.5

144.8

6276

45718

N05AH04

ATC

quetiapine; oral

1.5

144.4

4691

32193

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

144.1

8253

63310

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

143.5

2917

17860

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

143.0

1637

8393

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

6.0

142.9

254

428

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.4

141.9

528

1586

J01MA02

ATC

ciprofloxacin; systemic

1.4

141.4

10218

81489

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

141.3

7493

56648

SPAT1263

SPAT

Sampling

1.4

141.1

11332

91935

K90

ICPC

Stroke/cerebrovascular accident

2.6

141.0

858

3382

R01AD09

ATC

mometasone; nasal

1.4

140.7

12084

99074

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

140.2

1695

8856

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.8

140.1

702

2506

R00.2

ICD-10 Finland

Palpitations

1.8

140.0

2260

12956

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

139.6

3392

21741

CEC00

NOMESCO Finland

Recession of extraocular muscle

7.2

139.5

206

286

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

4.2

139.3

369

876

XF402

NOMESCO Finland

ECG with work load test

1.7

138.8

2705

16365

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.8

138.8

430

1144

CKD40

NOMESCO Finland

Endophotocoagulation of retina

3.6

138.5

470

1330

N03AE01

ATC

clonazepam; systemic

2.0

137.5

1529

7755

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

137.3

3200

20290

H47.1

ICD-10 Finland

Papilloedema, unspecified

5.9

136.7

248

426

R52.2

ICD-10 Finland

Other chronic pain

2.3

136.4

1104

4950

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

136.3

9165

72110

G47.3

ICD-10 Finland

Sleep apnoea

1.5

136.1

5813

42149

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

135.5

5120

36224

R50.9

ICD-10 Finland

Fever, unspecified

1.6

135.4

4149

28069

H52.1

ICD-10 Finland

Myopia

2.3

135.1

1079

4810

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

10.2

135.1

151

148

N06AB04

ATC

citalopram; systemic

1.5

133.1

5339

38215

C03CA01

ATC

furosemide; systemic

1.4

132.2

7762

59611

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

131.9

9717

77497

J01CA04

ATC

amoxicillin; systemic

1.4

131.5

22972

209669

E23.00

ICD-10 Finland

Panhypopituitarism

7.1

131.1

198

282

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

130.5

14123

119483

N05CF01

ATC

zopiclone; oral

1.4

130.2

8327

64856

A02BC01

ATC

omeprazole; systemic

1.4

130.1

7112

53912

K80

ICPC

Cardiac arrhythmia NOS

1.7

129.5

2383

14176

N07AA02

ATC

pyridostigmine; systemic

6.1

129.4

225

371

R11

ICD-10 Finland

Nausea and vomiting

1.7

129.3

2491

15011

Z01.2

ICD-10 Finland

Dental examination

1.3

129.3

12774

106544

Z2446

NOMESCO Finland

Social worker

1.9

129.1

1752

9508

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

4.0

128.8

370

933

P01AB01

ATC

metronidazole; oral, rectal

1.4

128.3

10474

84808

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

128.2

6608

49546

E0000UV, ,

ATC

1.4

128.1

11357

93130

C10AX09

ATC

ezetimibe; oral

1.5

128.0

4321

29824

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

127.5

1356

6765

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

126.9

5128

36715

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

126.9

5631

41057

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

126.7

2851

17896

K30

ICD-10 Finland

Functional dyspepsia

1.6

126.5

3114

19990

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.9

126.2

593

2044

H02AB09

ATC

hydrocortisone; systemic

2.6

125.9

728

2798

ZXA00

NOMESCO Finland

Right side

1.4

125.0

6601

49677

SPAT1301

SPAT

No procedures

1.4

123.8

8349

65482

UKC02

NOMESCO Finland

Cystoscopy

1.5

122.8

3981

27214

C09CA06

ATC

candesartan; oral

1.4

122.2

6318

47333

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

122.2

3816

25874

G43.8

ICD-10 Finland

Other migraine

3.2

122.0

499

1588

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.9

121.9

591

2072

ZXD05

NOMESCO Finland

Urgent procedure

1.4

121.8

7696

59678

SFA10

NOMESCO Finland

One-surface restoration

1.3

121.7

14857

127392

J01FA06

ATC

roxithromycin; oral

1.4

121.6

10099

81794

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

6.4

121.5

200

312

G70.0

ICD-10 Finland

Myasthenia gravis

6.9

121.4

188

275

R60.0

ICD-10 Finland

Localized oedema

1.6

121.3

3420

22657

N06AB10

ATC

escitalopram; oral

1.5

121.2

5348

38905

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.8

121.2

637

2332

SPAT1216

SPAT

Assessment of functional ability

1.5

120.6

4018

27619

L03AX13

ATC

glatiramer acetate; parenteral

6.4

119.9

198

310

J01FF01

ATC

clindamycin; systemic

1.4

119.6

6916

52808

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

119.4

2221

13242

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

119.0

18351

162522

L03AB07

ATC

interferon beta-1a; parenteral

5.5

118.9

228

413

K02.1

ICD-10 Finland

Caries of dentine

1.3

118.1

15898

137981

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

117.7

2718

17156

C08CA01

ATC

amlodipine; oral

1.4

117.5

9858

79852

N05BA01

ATC

diazepam; systemic, rectal

1.6

117.4

3264

21544

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

117.2

6484

49101

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.4

116.8

832

3528

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.3

116.5

921

4086

R06AE07

ATC

cetirizine; oral

1.3

116.4

11666

96984

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

116.4

15944

138589

J01FA10

ATC

azithromycin; systemic

1.3

116.3

15284

132062

G43.3

ICD-10 Finland

Complicated migraine

3.0

116.2

531

1802

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

115.6

2634

16564

S21

ICPC

Skin texture symptom/complaint

1.5

115.0

4140

28899

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

4.1

114.8

322

798

H25.8

ICD-10 Finland

Other senile cataract

1.6

114.7

2826

18119

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

114.5

2686

17013

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.9

114.3

556

1953

M54.2

ICD-10 Finland

Cervicalgia

1.7

113.6

2143

12819

3680A

ICD-9 Finland

Visual disturbances, Amblyopia ex anopsia

+∞

113.5

109

N03AX11

ATC

topiramate; oral

2.6

113.3

695

2749

L08

ICPC

Shoulder symptom/complaint

1.4

112.9

6031

45349

N30.0

ICD-10 Finland

Acute cystitis

1.5

112.7

4770

34372

M03BX01

ATC

baclofen; systemic

2.9

112.4

550

1938

H25.0

ICD-10 Finland

Senile incipient cataract

1.8

112.3

1733

9779

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

112.2

1481

7956

SFA20

NOMESCO Finland

Two-surface restoration

1.3

111.8

15482

134426

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.4

111.3

397

1161

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

110.3

4758

34392

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

110.0

5067

37075

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

109.9

1722

9761

WX892

NOMESCO Finland

Monitored bed care

1.7

109.5

1975

11663

A02BA02

ATC

ranitidine; systemic

1.5

109.2

4671

33702

R21

ICPC

Throat symptom/complaint

1.4

109.2

5726

42880

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

108.5

4463

31957

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

6.5

108.4

177

274

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

108.1

564

2057

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

107.9

3607

24764

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

107.7

2420

15153

N86

ICPC

Multiple sclerosis

4.7

107.5

251

540

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

4.0

107.4

307

772

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

107.3

3869

26983

J02AC01

ATC

fluconazole; systemic

1.3

106.8

10124

83178

H02.4

ICD-10 Finland

Ptosis of eyelid

2.3

106.7

840

3719

114

Kela drug reimbursment

Glaucoma

1.7

106.3

2198

13470

R05

ICD-10 Finland

Cough

1.4

106.1

5690

42748

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

105.8

929

4303

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

105.8

1690

9633

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

105.7

2417

15197

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.6

105.4

619

2397

A29

ICPC

General symptom/complaint other

1.5

105.1

3604

24865

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.8

104.9

329

883

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

104.8

1201

6148

C10AA01

ATC

simvastatin; oral

1.3

104.7

10217

84224

L04

ICPC

Chest symptom/complaint

1.8

104.0

1761

10209

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

103.7

2531

16171

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

103.7

9916

81477

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

3.7

103.6

334

914

J01DA01

ATC

[U] cefalexin

1.3

103.5

16118

141507

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.3

103.0

266

620

X58

ICD-10 Finland

Exposure to other specified factors

1.5

102.7

3821

26796

D11

ICPC

Diarrhoea

1.5

101.8

3199

21656

R74

ICPC

Upper respiratory infection acute

1.3

101.5

8674

70071

ZXE00

NOMESCO Finland

One hour or less

1.3

101.4

9880

81321

K07.60

ICD-10 Finland

Snapping jaw

1.9

101.2

1372

7429

H40.0

ICD-10 Finland

Glaucoma suspect

1.7

100.9

2048

12481

SPAT1254

SPAT

Administration of medicine

1.5

100.9

3912

27653

P20

ICPC

Memory disturbance

1.5

100.7

3554

24652

M01AE02

ATC

naproxen; oral, rectal

1.3

100.6

14884

129560

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

100.6

5550

41846

H29

ICPC

Ear symptom/complaint other

1.5

100.0

3254

22187

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

99.9

2618

17006

SPAT1260

SPAT

Consultation of another employee

1.4

99.7

4546

33133

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.1

99.6

275

674

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

99.1

1423

7847

U02

ICPC

Urinary frequency/urgency

1.5

99.0

4022

28682

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

98.7

6397

49507

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.6

98.2

325

905

S01ED01

ATC

timolol; ophthalmic

2.1

98.1

929

4431

C07AB02

ATC

metoprolol; systemic

1.4

98.0

4855

35904

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

97.9

2504

16168

R03DC03

ATC

montelukast; oral

1.5

97.8

4197

30234

N89

ICPC

Migraine

2.1

97.7

979

4772

A98

ICPC

Health maint/preventive medicine

1.8

97.7

27941

268606

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

97.6

10672

89118

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

97.5

2301

14569

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

97.4

1842

11010

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.4

97.2

672

2810

G50.1

ICD-10 Finland

Atypical facial pain

2.7

96.8

532

1993

SPAT1097

SPAT

Recording of ECG

1.5

96.6

3575

25021

SPAT1310

SPAT

Counselling related to known health issue

1.3

96.3

8189

65990

H52.5

ICD-10 Finland

Disorders of accommodation

8.6

96.3

123

144

164

Kela drug reimbursment

Fingolimod

7.2

96.3

143

200

G93.2

ICD-10 Finland

Benign intracranial hypertension

8.1

96.0

128

158

C01DA14

ATC

isosorbide mononitrate; oral

1.5

96.0

3655

25722

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

95.7

2028

12494

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

95.6

4097

29497

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

95.3

1283

6929

N06AB06

ATC

sertraline; oral

1.5

95.3

2865

19190

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

95.0

6508

50751

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

95.0

3379

23451

H01

ICPC

Ear pain/earache

1.5

94.7

3202

21990

L29

ICPC

Musculoskeletal sympt/complt other

1.6

94.6

2393

15406

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

94.5

9070

74311

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.5

94.3

323

920

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

94.1

2036

12610

H03AA01

ATC

levothyroxine sodium; systemic

1.4

94.0

5919

45539

C10AA07

ATC

rosuvastatin; oral

1.3

93.8

8349

67662

108

Kela drug reimbursment

Myasthenia gravis

7.0

93.7

143

206

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.5

93.7

621

2548

R51.81

ICD-10 Finland

Facial pain NOS

2.4

93.5

676

2884

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

93.3

2620

17281

KMAK, ,

NOMESCO Finland

1.3

93.1

12938

111261

L04AX07

ATC

dimethyl fumarate; oral

6.3

92.7

155

246

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

92.5

1578

9159

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

92.4

4245

30936

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

92.2

4076

29498

N06AB03

ATC

fluoxetine; oral

1.5

92.1

3011

20529

S01EA05

ATC

brimonidine; ophthalmic

2.3

92.0

683

2949

SPAT1229

SPAT

Assessment of need for aid

1.7

91.8

1914

11739

N02BF02

ATC

pregabalin; oral

1.7

91.6

1775

10675

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

91.5

1200

6425

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

91.2

5065

38148

U07

ICPC

Urine symptom/complaint other

1.6

91.1

2281

14644

N06AA09

ATC

amitriptyline; systemic

1.6

90.5

2309

14888

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.2

90.5

372

1188

H02AB04

ATC

methylprednisolone; systemic

1.5

90.4

3544

25059

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.9

90.4

268

692

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.3

90.3

234

547

A99

ICPC

Disease/condition unspecnature/site

1.5

90.1

2755

18509

L02

ICPC

Back symptom/complaint

1.5

89.7

2722

18254

R01AD08

ATC

fluticasone; nasal

1.3

89.5

7095

56473

S01EE01

ATC

latanoprost; ophthalmic

1.7

89.5

1583

9283

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

89.1

2972

20336

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

89.0

7514

60344

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

88.9

1921

11887

J05AB01

ATC

aciclovir; systemic

1.4

88.9

5506

42195

A97

ICPC

No disease

1.4

88.8

5340

40730

K89

ICPC

Transient cerebral ischaemia

3.4

88.4

322

955

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

88.3

2683

17996

R4110, ,

SPAT

1.5

88.3

3452

24391

L15

ICPC

Knee symptom/complaint

1.3

88.0

6563

51751

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.0

87.9

387

1286

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

87.9

3034

20907

H02AB07

ATC

prednisone; oral

1.5

87.8

3294

23082

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

87.7

1625

9653

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

87.6

1061

5531

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.2

87.5

353

1115

A03

ICPC

Fever

1.4

87.3

4505

33483

D07AC01

ATC

betamethasone; topical

1.3

87.1

9301

77091

SFA30

NOMESCO Finland

Three-surface restoration

1.3

87.1

10628

89631

B01AC07

ATC

dipyridamole; systemic

2.0

86.6

965

4887

H35.6

ICD-10 Finland

Retinal haemorrhage

4.1

86.4

239

587

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

86.3

2648

17793

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

86.3

1962

12297

B01AF02

ATC

apixaban; oral

1.5

86.2

3340

23548

WX290

NOMESCO Finland

Other blockage of nerve

1.3

85.7

12130

104156

N18

ICPC

Paralysis/weakness

2.5

85.6

545

2194

K04

ICPC

Palpitations/awareness of heart

1.8

85.5

1411

8109

F01

ICPC

Eye pain

2.1

85.4

843

4084

-1, ,

NOMESCO Finland

1.3

85.4

8377

68608

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

85.3

5547

42802

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

85.2

6995

55883

H93.1

ICD-10 Finland

Tinnitus

1.7

85.1

1760

10764

H02

ICPC

Hearing complaint

1.4

85.0

3746

27055

183

Kela drug reimbursment

Lamotrigin and topiramate

3.6

84.9

286

806

ZY010

NOMESCO Finland

Hospital outpatient

1.8

84.8

1303

7330

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

6.2

84.5

144

233

D02

ICPC

Abdominal pain epigastric

1.7

84.4

1669

10087

L13

ICPC

Hip symptom/complaint

1.4

84.3

4968

37726

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

84.3

3391

24075

B01AB05

ATC

enoxaparin; parenteral

1.3

84.2

7897

64257

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

84.1

5134

39206

P06

ICPC

Sleep disturbance

1.5

84.0

3286

23201

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

83.9

3679

26543

Z00.0

ICD-10 Finland

General medical examination

1.4

83.8

4960

37689

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.0

83.7

976

5021

N03AF01

ATC

carbamazepine; oral, rectal

1.8

83.4

1193

6565

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

83.3

890

4440

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

83.1

6514

51667

N02AA05

ATC

oxycodone; systemic

1.4

83.0

4500

33695

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

82.8

2231

14558

K08.80

ICD-10 Finland

Toothache NOS

1.6

82.7

2287

15012

353

Kela drug reimbursment

Cladribine and fingolimod

6.9

82.4

127

185

P01

ICPC

Feeling anxious/nervous/tense

1.5

82.2

3254

23020

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

82.0

730

3399

SPAT1153

SPAT

Removal of sutures

1.3

82.0

7711

62723

R01AD58

ATC

fluticasone, combinations; nasal

1.3

81.9

6219

49077

R06AX27

ATC

desloratadine; oral

1.3

81.4

7254

58554

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.5

81.2

282

811

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

81.1

2041

13105

XQ800

NOMESCO Finland

Prick test

1.6

81.0

1790

11131

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

80.9

2516

16944

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

80.9

2135

13863

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

80.8

2674

18246

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

80.7

4230

31478

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

80.2

1733

10716

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

80.0

526

2150

R12

ICD-10 Finland

Heartburn

1.6

79.9

2155

14060

C09AA05

ATC

ramipril; oral

1.3

79.9

5904

46382

R35

ICD-10 Finland

Polyuria

1.7

79.8

1689

10390

R07.0

ICD-10 Finland

Pain in throat

1.6

79.7

1877

11858

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

79.7

5957

46874

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.3

79.6

302

919

T78.4

ICD-10 Finland

Allergy, unspecified

1.8

79.6

1170

6493

M01AB05

ATC

diclofenac; systemic, rectal

1.3

79.5

16983

152593

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.9

79.5

233

597

PA2AD

NOMESCO Finland

CT angiography of brain

3.3

79.4

297

896

SPAT1240

SPAT

Therapeutic discussion

1.5

79.2

2555

17338

L05

ICPC

Flank/axilla symptom/complaint

1.7

78.9

1641

10048

L04AA27

ATC

[U] fingolimod

8.1

78.6

105

130

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

78.4

2123

13863

L16

ICPC

Ankle symptom/complaint

1.5

77.8

3092

21875

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.3

77.6

631

2832

R03BA05

ATC

fluticasone; inhalant

1.4

77.5

4517

34190

R03BA02

ATC

budesonide; inhalant

1.4

77.3

4430

33434

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.3

76.8

620

2774

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

76.7

5531

43257

CKD15

NOMESCO Finland

Injection of vitreous substitute

4.7

76.6

175

370

N06AX26

ATC

vortioxetine; oral

1.6

76.5

1914

12267

H50.9

ICD-10 Finland

Strabismus, unspecified

6.3

76.3

128

204

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

76.1

2313

15494

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.8

76.0

397

1449

J01MA12

ATC

levofloxacin; systemic

1.4

75.8

4399

33257

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

75.4

1899

12189

R03BA08

ATC

ciclesonide; inhalant

1.6

75.3

2122

13975

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.0

75.3

860

4393

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

75.1

2406

16297

WX402

NOMESCO Finland

General anaesthesia

1.3

74.9

5595

43964

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

74.9

1846

11787

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

74.6

1413

8435

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

74.6

486

1979

N05BA09

ATC

clobazam; oral

4.0

74.5

210

523

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

74.5

3324

24020

A06AD11

ATC

lactulose; oral

1.4

74.5

3494

25476

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

74.3

4905

37830

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.9

74.3

912

4775

C01CA24

ATC

epinephrine; parenteral

1.7

74.1

1496

9086

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

73.9

2135

14137

S01EC04

ATC

brinzolamide; ophthalmic

1.9

73.9

978

5249

H16.0

ICD-10 Finland

Corneal ulcer

1.8

73.8

1194

6819

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

73.7

3030

21561

R96

ICPC

Asthma

1.5

73.7

2508

17198

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

73.6

3116

22294

W19

ICD-10 Finland

Unspecified fall

1.5

73.5

2499

17133

D12

ICPC

Constipation

1.9

73.4

994

5374

R04.0

ICD-10 Finland

Epistaxis

1.6

73.4

1830

11715

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

73.4

1022

5576

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

73.3

1551

9533

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

4.4

73.3

186

428

CEW99

NOMESCO Finland

Other operation on extraocular muscle

12.7

73.2

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

73.0

2337

15822

M79.7

ICD-10 Finland

Fibromyalgia

1.9

73.0

890

4649

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

72.9

4244

32083

207

Kela drug reimbursment

Chronic arrhythmias

1.4

72.5

3759

27876

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

72.5

1243

7218

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

72.2

2405

16417

H50.8

ICD-10 Finland

Other specified strabismus

8.3

72.1

113

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

71.9

1384

8298

S04

ICPC

Lump/swelling localized

1.5

71.9

2817

19861

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

71.8

9994

85065

J01EA01

ATC

trimethoprim; systemic

1.3

71.6

6498

52419

F28

ICPC

Limited function/disability (F)

3.7

71.3

230

630

P03

ICPC

Feeling depressed

1.5

71.2

2549

17652

N07CA01

ATC

betahistine; oral

1.6

71.2

1731

11012

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

71.2

1624

10173

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

3.8

71.1

220

586

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.8

71.1

1124

6375

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

71.0

2586

17971

K91

ICPC

Cerebrovascular disease

2.8

71.0

369

1344

M48.0

ICD-10 Finland

Spinal stenosis

1.4

70.9

2953

21055

AN1

Coronary angiography

1.5

70.9

2435

16723

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

70.6

3118

22471

N05CF02

ATC

zolpidem; oral

1.4

70.5

4115

31103

J01FA09

ATC

clarithromycin; systemic

1.3

70.5

7607

62742

N03AX18

ATC

lacosamide; systemic

3.4

70.3

255

755

R01AD12

ATC

fluticasone furoate; nasal

1.3

70.1

7764

64233

H3603, E103,

ICD-10 Finland

3.3

69.9

271

836

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

69.9

742

3693

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.5

69.7

427

1689

L14

ICPC

Leg/thigh symptom/complaint

1.5

69.4

2101

14048

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

69.4

1676

10645

N29

ICPC

Neurological sympt/complt other

2.3

69.2

526

2294

D19

ICPC

Teeth/gum symptom/complaint

1.3

69.2

7817

64817

H43.3

ICD-10 Finland

Other vitreous opacities

2.6

69.1

402

1550

M54.8

ICD-10 Finland

Other dorsalgia

1.8

69.0

1172

6786

EBA00

NOMESCO Finland

Extraction of tooth

1.3

69.0

9304

78803

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

68.7

1868

12196

SPAT1312

SPAT

General health counselling

1.3

68.6

8043

66978

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.5

68.3

446

1818

XKD00

NOMESCO Finland

Uroflowmetry

1.4

68.3

3408

25089

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

68.3

842

4415

J20

ICD-10 Finland

Acute bronchitis

1.5

68.2

2592

18156

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.9

68.2

839

4396

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

67.9

1162

6741

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

10.7

67.7

I95.1

ICD-10 Finland

Orthostatic hypotension

1.8

67.6

958

5254

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

67.5

3140

22832

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

67.5

6490

52691

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

67.4

7676

63666

R5110, ,

SPAT

1.5

67.3

2158

14605

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

67.3

716

3566

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

67.2

786

4047

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

67.1

1171

6831

R03AC03

ATC

terbutaline; inhalant

1.4

67.1

3285

24097

R83

ICPC

Respiratory infection other

1.3

67.0

6296

50949

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

67.0

1420

8729

G04BD12

ATC

mirabegron; oral

1.4

66.9

2924

21021

37300

ICD-8 Finland

Strabismus, Concomitans convergens

3.9

66.9

195

498

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

3.5

66.7

234

678

S22.3

ICD-10 Finland

Fracture of rib

1.6

66.7

1699

10925

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

66.4

2456

17109

A08

ICPC

Swelling

1.6

66.3

1444

8937

S80.0

ICD-10 Finland

Contusion of knee

1.5

66.3

1902

12566

H92.0

ICD-10 Finland

Otalgia

1.6

66.1

1623

10346

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

2.9

66.0

305

1043

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

66.0

536

2405

P76

ICPC

Depressive disorder

1.6

65.9

1635

10447

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

65.9

6661

54396

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

65.9

1050

5968

SPAT1234

SPAT

Support of social functional capacity

1.7

65.7

1250

7467

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

65.7

4703

36635

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

65.4

5364

42601

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

65.2

1043

5933

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.6

65.2

378

1456

Z01.7

ICD-10 Finland

Laboratory examination

1.4

65.1

4166

31906

XCW10

NOMESCO Finland

Assessment of vision

2.4

65.0

436

1800

P29

ICPC

Psychological sympt/compl other

1.5

65.0

1854

12233

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

64.9

1137

6639

D09

ICPC

Nausea

1.7

64.7

1233

7370

CEC30

NOMESCO Finland

Resection of extraocular muscle

8.9

64.7

M01AH05

ATC

etoricoxib; oral

1.2

64.3

15876

143263

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.4

64.2

458

1943

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

64.2

2660

18932

WX872

NOMESCO Finland

Intensive care

1.7

64.0

1160

6838

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

64.0

1729

11267

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

64.0

5105

40369

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

64.0

2690

19196

Z00.8

ICD-10 Finland

Other general examinations

1.5

63.4

2007

13539

I63.8

ICD-10 Finland

Other cerebral infarction

3.2

63.4

257

815

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

63.3

1819

12019

K59.0

ICD-10 Finland

Constipation

1.6

63.1

1417

8836

G04CA02

ATC

tamsulosin; oral

1.3

62.9

4956

39109

C08DA01

ATC

verapamil; systemic

1.8

62.9

965

5421

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

62.9

1396

8681

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

62.7

3291

24410

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

62.6

811

4321

A02BC04

ATC

rabeprazole; oral

1.5

62.6

2039

13837

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

62.5

5544

44458

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

62.4

6969

57552

315

Kela drug reimbursment

Clopidogrel

3.1

62.4

266

869

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

62.1

1796

11881

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

62.1

6443

52722

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

62.0

976

5525

M01AH01

ATC

celecoxib; oral

1.3

62.0

4196

32386

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.0

62.0

653

3241

P74

ICPC

Anxiety disorder/anxiety state

1.7

61.9

1112

6538

H26.2

ICD-10 Finland

Complicated cataract

2.7

61.8

330

1219

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

61.8

752

3925

N04BC05

ATC

pramipexole; oral

1.5

61.7

1780

11770

L04AA31

ATC

[U] teriflunomide

5.8

61.4

112

194

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

61.4

1423

8942

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

61.3

2290

15973

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

60.5

1079

6333

A05

ICPC

Feeling ill

1.6

60.5

1571

10144

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

60.4

1115

6606

XCW12

NOMESCO Finland

Assessment of colour vision

14.6

60.3

D35.30

ICD-10 Finland

Craniopharyngoma

18.5

60.3

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

60.2

666

3364

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

60.0

1476

9407

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.6

59.9

351

1359

EB1VA, ,

NOMESCO Finland

1.3

59.7

4359

34003

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

59.6

6948

57623

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

59.5

1493

9560

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

59.5

1621

10579

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

59.4

8172

69084

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

59.4

6356

52164

H47.3

ICD-10 Finland

Other disorders of optic disc

4.7

59.3

135

285

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

59.2

2237

15631

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

59.0

4304

33564

M54.1

ICD-10 Finland

Radiculopathy

1.8

59.0

936

5312

N28

ICPC

Limited function/disability (N)

2.3

59.0

442

1917

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

58.9

973

5588

ZXD20

NOMESCO Finland

Day surgery

1.4

58.8

2917

21414

L86

ICPC

Back syndrome with radiating pain

1.6

58.7

1516

9772

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

58.7

10180

88229

J01DA09

ATC

[U] cefadroxil

1.3

58.7

6197

50761

CKD20

NOMESCO Finland

Removal of vitreous body substitute

4.0

58.7

168

424

J45

ICD-10 Finland

Asthma

1.4

58.5

2539

18206

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

58.4

915

5173

K85

ICPC

Elevated blood pressure

1.3

58.4

4035

31217

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

58.2

3256

24384

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

58.1

3224

24112

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.7

58.1

1167

7072

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

57.8

805

4391

PD5AD

NOMESCO Finland

CT of aorta

2.1

57.7

587

2876

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.8

57.7

298

1083

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

57.6

599

2959

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

57.5

2560

18439

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

57.2

1052

6224

R4130

NOMESCO Finland

Speech therapy

2.0

56.9

629

3176

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

3.4

56.8

201

586

H35.7

ICD-10 Finland

Separation of retinal layers

3.0

56.8

258

874

M05BA04

ATC

alendronic acid; oral

1.5

56.8

2018

13929

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

56.7

1167

7115

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.1

56.5

542

2599

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

3.5

56.4

192

546

H13

ICPC

Plugged feeling ear

1.3

56.4

4722

37514

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

4.8

56.4

127

266

SPAT1325

SPAT

Vaccination

1.2

56.3

8224

69889

M02AA07

ATC

piroxicam; topical

1.2

56.3

8453

72059

K78

ICPC

Atrial fibrillation/flutter

1.5

56.1

1764

11873

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

56.1

796

4366

C08CA13

ATC

lercanidipine; oral

1.4

55.9

3414

25908

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

55.8

1422

9137

H33.5

ICD-10 Finland

Other retinal detachments

3.1

55.6

234

759

K29

ICPC

Cardiovascular sympt/complt other

1.7

55.5

1049

6255

P99

ICPC

Psychological disorders other

1.9

55.4

726

3884

C09CA01

ATC

losartan; oral

1.3

55.3

6067

49868

S82

ICPC

Naevus/mole

1.4

55.1

3465

26408

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

2.8

55.1

272

965

S16

ICPC

Bruise/contusion

1.8

55.1

798

4406

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

55.0

12295

109111

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

2.5

54.8

354

1437

H26.02

ICD-10 Finland

Presenil cataract

2.0

54.6

623

3181

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.9

54.6

258

894

A23

ICPC

Risk factor NOS

1.4

54.5

2350

16823

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

54.5

2598

18932

M54

ICD-10 Finland

Dorsalgia

1.4

54.5

2982

22237

I49.1

ICD-10 Finland

Atrial premature depolarization

1.8

54.5

891

5101

N05BA12

ATC

alprazolam; oral

1.4

54.3

2199

15560

XCD20

NOMESCO Finland

Photoangiography of eye

2.4

54.3

390

1661

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.8

54.2

273

979

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.6

54.2

1196

7423

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

2.5

54.1

338

1350

U05

ICPC

Urination problems other

1.6

54.1

1263

7946

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.8

54.1

268

953

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

2.8

54.1

276

997

N06AX12

ATC

bupropion; oral

1.5

54.0

1624

10828

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

53.9

992

5870

SAA04

NOMESCO Finland

Special examination of mouth

1.6

53.8

1256

7904

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.6

53.6

318

1239

J05AB11

ATC

valaciclovir; oral

1.3

53.6

3440

26292

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

53.6

1546

10216

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

53.5

1686

11351

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

53.5

579

2902

S01

ICPC

Pain/tenderness of skin

1.6

53.5

1146

7060

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

53.4

1465

9574

3682A

ICD-9 Finland

Visual disturbances, Diplopia

+∞

53.1

3681A

ICD-9 Finland

Visual disturbances, Subjective visual disturbances

+∞

53.1

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

53.0

1024

6140

R03BA01

ATC

beclometasone; inhalant

1.4

53.0

3222

24422

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

53.0

400

1741

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

53.0

7022

58956

F94

ICPC

Blindness

15.3

52.7

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.9

52.5

249

865

R52.0

ICD-10 Finland

Acute pain

1.8

52.4

797

4467

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.7

52.3

282

1048

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

52.3

1107

6799

K07

ICPC

Swollen ankles/oedema

1.6

52.1

1154

7166

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

52.0

1640

11042

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.3

52.0

388

1680

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

51.8

1363

8822

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

51.7

1258

7994

C10AA03

ATC

pravastatin; oral

1.5

51.6

1601

10742

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.3

51.5

380

1638

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

51.4

1659

11226

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

5.4

51.2

100

185

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.0

51.2

534

2642

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

51.1

749

4151

F13

ICPC

Eye sensation abnormal

1.9

51.1

712

3885

M01AX17

ATC

nimesulide; oral

1.3

51.0

5380

43952

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.0

50.9

227

762

102

Kela drug reimbursment

Diabetes insipidus

6.1

50.8

145

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

50.8

703

3826

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

50.8

1441

9483

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.0

50.7

229

774

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

50.7

486

2330

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

50.7

914

5379

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.4

50.7

347

1447

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

50.6

2144

15291

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

50.5

1220

7738

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

50.3

297

1155

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

3.2

50.3

198

618

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

50.3

1295

8340

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.9

50.3

238

826

R52.1

ICD-10 Finland

Chronic intractable pain

2.8

50.2

245

864

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

2.3

50.2

398

1769

S01EE03

ATC

bimatoprost; ophthalmic

2.0

50.1

532

2648

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

50.1

2107

15005

S01EC54

ATC

brinzolamide, combinations; ophthalmic

2.4

50.1

348

1461

2AB04, ,

NOMESCO Finland

5.8

49.8

158

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

3.7

49.8

156

420

A03FA02

ATC

cisapride; oral, rectal

1.5

49.8

1663

11330

R1250

NOMESCO Finland

Evaluation of functional capability

1.9

49.8

591

3060

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.3

49.6

390

1728

A10AB05

ATC

insulin aspart; parenteral

1.5

49.5

1723

11837

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

49.4

1995

14102

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

2.8

49.3

244

867

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

49.3

495

2414

F95

ICPC

Strabismus

7.0

49.3

108

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

49.1

601

3144

U01

ICPC

Dysuria/painful urination

1.4

49.1

1961

13833

L03AB08

ATC

interferon beta-1b; parenteral

5.3

49.1

185

S22

ICPC

Nail symptom/complaint

1.5

49.0

1624

11046

R31

ICD-10 Finland

Unspecified haematuria

1.4

48.9

2252

16296

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

48.9

8740

75602

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

48.9

1669

11421

I20.09

ICD-10 Finland

Unstable angina

1.6

48.8

1213

7745

M54.3

ICD-10 Finland

Sciatica

1.6

48.8

1353

8858

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

3.0

48.7

221

749

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.5

48.7

301

1197

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

48.6

802

4603

WX704

NOMESCO Finland

Intubation

1.4

48.6

1906

13399

L04AG12

ATC

ofatumumab; parenteral

8.7

48.6

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

48.5

1108

6933

L18

ICPC

Muscle pain

1.6

48.4

1042

6425

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

48.4

717

3986

J01CA08

ATC

pivmecillinam; oral

1.2

48.4

10231

89939

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

3.8

48.3

149

397

G04CA01

ATC

alfuzosin; oral

1.4

48.3

2449

18017

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

48.3

2877

21721

G44.0

ICD-10 Finland

Cluster headache syndrome

2.6

48.2

275

1052

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.7

48.1

254

934

H33.4

ICD-10 Finland

Traction detachment of retina

5.8

48.1

153

G43

ICD-10 Finland

Migraine

1.6

48.1

1192

7607

M02AA10

ATC

ketoprofen; topical

1.3

47.9

3640

28476

R06.5

ICD-10 Finland

Mouth breathing

1.4

47.9

1961

13896

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

3.2

47.8

187

581

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

47.8

905

5396

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

47.8

729

4088

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

47.8

3263

25139

L04AX01

ATC

azathioprine; systemic

1.7

47.7

955

5780

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.5

47.6

293

1163

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

3.6

47.6

154

424

A10AE04

ATC

insulin glargine; parenteral

1.4

47.6

2131

15345

H50.4

ICD-10 Finland

Other and unspecified heterotropia

9.5

47.6

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

47.6

1661

11416

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

47.5

3141

24083

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

2.3

47.5

349

1502

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

47.3

1313

8598

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

47.3

2637

19700

H01.0

ICD-10 Finland

Blepharitis

1.5

47.2

1612

11029

N05AX12

ATC

aripiprazole; systemic

1.7

47.2

878

5211

G44.8

ICD-10 Finland

Other specified headache syndromes

2.3

47.2

365

1606

R09

ICPC

Sinus symptom/complaint

1.4

47.1

1906

13473

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

47.1

1390

9225

A27

ICPC

Fear of other disease NOS

1.6

47.1

1197

7683

R03BB04

ATC

tiotropium bromide; inhalant

1.4

47.0

2185

15833

ZX120

NOMESCO Finland

Intravenous

1.4

46.9

2087

15008

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

46.9

2147

15518

R25.2

ICD-10 Finland

Cramp and spasm

1.9

46.9

597

3165

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

46.7

1689

11685

SDA03

NOMESCO Finland

Periodontal treatment

1.2

46.7

10060

88504

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

46.7

757

4324

SGA01

NOMESCO Finland

Emergency treatment

1.3

46.6

3676

28892

SPAT1104

SPAT

Monitoring of emergency patient

1.5

46.6

1444

9682

K04.08

ICD-10 Finland

Other specified pulpit

1.5

46.5

1731

12043

K04.0

ICD-10 Finland

Pulpitis

1.4

46.5

1990

14212

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

46.5

730

4130

H44.2

ICD-10 Finland

Degenerative myopia

5.9

46.4

138

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.0

46.4

497

2483

UDC00

NOMESCO Finland

Ear microscopy

1.5

46.4

1714

11911

N06AA10

ATC

nortriptyline; systemic

2.1

46.3

470

2302

SFA00

NOMESCO Finland

Small restoration

1.3

46.3

3251

25144

R09.1

ICD-10 Finland

Pleurisy

2.1

46.2

439

2098

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.7

46.2

823

4827

A46

ICD-10 Finland

Erysipelas

1.3

46.2

3383

26318

N05AH03

ATC

olanzapine; systemic

1.5

46.1

1374

9136

L84

ICPC

Back syndrome without radiat pain

1.6

46.1

1109

7026

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

46.1

1141

7278

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.7

46.1

812

4749

L04AA06

ATC

mycophenolic acid; systemic

2.1

46.0

450

2175

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.7

45.9

829

4880

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

45.9

17407

161044

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

3.6

45.7

153

431

SPAT1050

SPAT

Extensive neurological examination

2.0

45.7

498

2504

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

9.6

45.5

SPAT1053

SPAT

Memory test

1.3

45.5

3139

24208

WZC30

NOMESCO Finland

Teaching

1.3

45.4

3828

30348

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

45.3

579

3072

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

45.3

3725

29433

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

11.8

45.3

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.0

45.3

492

2471

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

4.9

45.2

199

L20

ICPC

Joint symptom/complaint NOS

1.7

45.2

929

5662

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

45.1

2463

18331

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

45.1

191

623

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

45.1

1022

6384

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

45.0

4419

35721

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

45.0

2218

16232

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

44.9

980

6062

T89

ICPC

Diabetes insulin dependent

1.7

44.9

865

5184

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.8

44.7

670

3738

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

44.7

2773

21051

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.5

44.7

1267

8335

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

44.7

1381

9255

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

44.7

853

5099

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

44.6

1365

9128

H44.5

ICD-10 Finland

Degenerated conditions of globe

8.0

44.6

F45.0

ICD-10 Finland

Somatization disorder

3.7

44.5

141

383

R3120

NOMESCO Finland

Training in mobility skills

3.8

44.4

135

356

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

8.9

44.4

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

44.4

3794

30129

RS221, ,

NOMESCO Finland

2.3

44.3

336

1466

H27.0

ICD-10 Finland

Aphakia

4.7

44.3

102

218

N64.4

ICD-10 Finland

Mastodynia

1.7

44.2

790

4638

ZXC95

NOMESCO Finland

Use of surgical navigator

2.4

44.0

300

1249

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

44.0

1615

11204

R06.4

ICD-10 Finland

Hyperventilation

2.2

43.8

376

1727

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

43.8

1180

7674

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

4.0

43.5

123

308

L57.0

ICD-10 Finland

Actinic keratosis

1.4

43.5

2439

18224

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

43.4

3114

24138

L60.0

ICD-10 Finland

Ingrowing nail

1.6

43.4

1132

7308

G51.0

ICD-10 Finland

Bell palsy

1.9

43.4

585

3159

SPAT1043

SPAT

Audiometry

1.4

43.4

2265

16732

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

43.2

974

6075

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

43.1

920

5659

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

6.1

43.1

121

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

43.1

5064

41791

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

42.9

1803

12827

S01EE05

ATC

tafluprost; ophthalmic

1.7

42.9

790

4675

N07XX09

ATC

[U] dimethyl fumarate

5.5

42.8

149

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

42.8

1893

13593

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.8

42.7

650

3643

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.9

42.7

196

669

ZXD35

NOMESCO Finland

Usual procedure

1.8

42.7

712

4099

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.9

42.7

551

2934

H50.6

ICD-10 Finland

Mechanical strabismus

11.9

42.7

H35.8

ICD-10 Finland

Other specified retinal disorders

3.3

42.7

161

490

H43.9

ICD-10 Finland

Disorder of vitreous body, unspecified

2.6

42.6

247

953

J01MA06

ATC

norfloxacin; oral

1.3

42.5

2864

22003

H36.01

ICD-10 Finland

Diabetic maculopathy

2.4

42.5

301

1276

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

42.4

2696

20531

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

4.7

42.4

210

N76.0

ICD-10 Finland

Acute vaginitis

1.5

42.4

1443

9864

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

42.3

1089

7008

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.8

42.3

209

743

R5599

NOMESCO Finland

Other rehabilitation service

1.8

42.2

623

3460

A10AC01

ATC

insulin (human); parenteral

1.5

42.2

1585

11044

R07.2

ICD-10 Finland

Precordial pain

2.0

42.2

490

2519

CKC15

NOMESCO Finland

Panretinal photocoagulation

2.9

42.1

198

685

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

42.1

1366

9246

R01AD01

ATC

beclometasone; nasal

1.3

42.0

3335

26209

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

42.0

3113

24238

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.7

42.0

751

4411

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

41.9

1881

13540

W10

ICD-10 Finland

Fall on and from stairs and steps

1.5

41.8

1188

7817

R06AX22

ATC

ebastine; oral

1.3

41.8

3854

30881

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

41.8

9406

82848

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

3.0

41.8

185

619

S20.2

ICD-10 Finland

Contusion of thorax

1.5

41.7

1187

7816

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

41.6

759

4482

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.5

41.5

1290

8652

M01AC06

ATC

meloxicam; systemic, rectal

1.2

41.5

8373

73007

N05CD07

ATC

temazepam; oral

1.4

41.3

2469

18629

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

41.3

2132

15717

R06.2

ICD-10 Finland

Wheezing

1.6

41.2

1016

6474

R33

ICD-10 Finland

Retention of urine

1.4

41.2

1642

11568

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

3.3

41.1

153

462

N06AX22

ATC

agomelatine; oral

1.9

41.0

519

2746

R44.1

ICD-10 Finland

Visual hallucinations

3.2

40.9

158

488

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

40.9

704

4091

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.0

40.8

438

2190

Z31.5

ICD-10 Finland

Genetic counselling

1.5

40.8

1170

7715

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.1

40.8

407

1983

SPAT1211

SPAT

Application of soft bandage

1.4

40.6

1995

14583

K24

ICPC

Fear of heart disease

1.8

40.6

599

3328

L95

ICPC

Osteoporosis

1.6

40.5

912

5686

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

40.5

8542

74746

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

40.5

477

2465

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

40.4

2970

23089

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

40.4

1961

14306

L09

ICPC

Arm symptom/complaint

1.5

40.4

1145

7532

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

40.4

2537

19283

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

40.3

881

5452

D07AC13

ATC

mometasone; topical

1.2

40.3

6706

57362

N04BB01

ATC

amantadine; oral

2.2

40.3

347

1597

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

40.2

5936

50169

D07AD01

ATC

clobetasol; topical

1.3

40.2

3845

30943

L11

ICPC

Wrist symptom/complaint

1.4

40.1

2211

16467

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

40.1

864

5328

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

40.1

524

2803

C03DA01

ATC

spironolactone; oral

1.3

40.0

2775

21393

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

40.0

1252

8410

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

40.0

1702

12135

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.7

39.9

780

4691

R06AX13

ATC

loratadine; oral

1.3

39.9

3310

26155

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

39.7

929

5846

A91

ICPC

Abnormal result investigation NOS

1.5

39.7

1214

8116

A07AA02

ATC

nystatin; oral

1.5

39.6

1285

8697

J46

ICD-10 Finland

Status asthmaticus

1.8

39.6

650

3727

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.4

39.5

143

424

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

2.7

39.5

215

804

N30

ICD-10 Finland

Cystitis

1.4

39.5

1973

14459

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.5

39.5

1187

7905

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

39.5

5850

49443

U71

ICPC

Cystitis/urinary infection other

1.4

39.5

1646

11692

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

39.4

1891

13764

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

39.4

522

2803

Z97.0

ICD-10 Finland

Presence of artificial eye

9.1

39.4

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

39.4

5012

41682

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

39.2

1578

11135

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

39.2

1292

8771

ZXY02

NOMESCO Finland

Neuropsychologist

3.3

39.2

146

441

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.8

39.2

552

3023

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.0

39.2

417

2080

XKC03

NOMESCO Finland

Water cystometry

1.7

39.1

661

3821

H81

ICPC

Excessive ear wax

1.3

39.1

4045

32849

M89.0

ICD-10 Finland

Algoneurodystrophy

2.7

39.1

211

786

S01EA03

ATC

apraclonidine; ophthalmic

2.5

39.1

241

959

G40.10

ICD-10 Finland

Simple partial seizures

2.9

39.0

189

665

H02.3

ICD-10 Finland

Blepharochalasis

1.5

39.0

1445

10038

DAX08

NOMESCO Finland

Fitting of hearing aid

1.5

38.9

1262

8541

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

38.9

1323

9040

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

38.9

1757

12660

L29.9

ICD-10 Finland

Pruritus, unspecified

1.7

38.8

650

3748

M01AH02

ATC

rofecoxib; oral

1.3

38.8

2730

21088

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

38.5

3343

26559

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.6

38.5

222

855

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.3

38.5

298

1313

Q12.0

ICD-10 Finland

Congenital cataract

7.6

38.5

R29

ICPC

Respiratory symptom/complaint other

1.4

38.4

1562

11042

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

38.4

1807

13108

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.2

38.4

344

1608

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

38.4

2456

18707

K05

ICPC

Irregular heartbeat other

1.7

38.4

729

4351

C08CA05

ATC

nifedipine; systemic

1.5

38.4

1289

8784

C05AA08

ATC

fluocortolone; rectal, topical

1.3

38.3

2940

22979

M05BX04

ATC

denosumab; parenteral

1.5

38.1

1401

9719

R20.0

ICD-10 Finland

Anaesthesia of skin

2.7

38.1

210

791

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.3

38.0

287

1252

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

38.0

803

4930

S01BC03

ATC

diclofenac; ophthalmic

1.9

37.9

479

2535

R30.0

ICD-10 Finland

Dysuria

1.6

37.8

992

6412

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

37.8

1391

9650

R41.3

ICD-10 Finland

Other amnesia

1.7

37.8

659

3844

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

37.7

1112

7376

H57.0

ICD-10 Finland

Anomalies of pupillary function

3.1

37.7

158

513

G54.0

ICD-10 Finland

Brachial plexus disorders

1.8

37.6

542

2990

F34.1

ICD-10 Finland

Dysthymia

1.7

37.6

784

4796

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

1.7

37.5

736

4431

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

37.5

800

4922

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.2

37.5

314

1430

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.4

37.4

255

1063

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

37.4

837

5212

X18

ICPC

Breast pain female

2.1

37.4

373

1818

J01DA06

ATC

[U] cefuroxime

1.3

37.3

3098

24467

S00.0

ICD-10 Finland

Superficial injury of scalp

1.8

37.3

548

3042

H50.59

ICD-10 Finland

Heterophor UNS

6.5

37.2

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.1

37.2

347

1648

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

37.2

1009

6571

M35.7

ICD-10 Finland

Hypermobility syndrome

2.2

37.2

317

1454

A01AB09

ATC

miconazole; local oral

1.4

37.1

1890

13891

H33.2

ICD-10 Finland

Serous retinal detachment

4.7

37.1

181

E000001, ,

ATC

1.2

37.0

4518

37375

SBB10

NOMESCO Finland

Dental impressions

1.4

37.0

1551

11027

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

37.0

1238

8432

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

1.8

37.0

572

3224

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

36.9

1492

10538

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

36.8

1683

12146

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

6.0

36.8

106

N06AX03

ATC

mianserin; oral

1.6

36.8

995

6475

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

36.7

700

4183

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3.6

36.7

122

343

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

36.6

858

5404

D03

ICPC

Heartburn

1.6

36.5

863

5445

S01BC05

ATC

ketorolac; ophthalmic

1.7

36.5

750

4571

K03.66

ICD-10 Finland

Tooth plaque

1.4

36.5

1803

13188

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

3.7

36.5

117

321

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

36.4

543

3027

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

36.4

677

4019

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

36.4

1322

9151

G04CB01

ATC

finasteride; oral

1.4

36.3

2078

15560

S97

ICPC

Chronic ulcer skin

1.4

36.3

1396

9768

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

36.3

2284

17353

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

36.2

864

5463

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

36.2

1664

12023

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

4.1

36.1

100

247

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

3.3

36.1

137

419

K92.1

ICD-10 Finland

Melaena

1.5

36.0

1158

7821

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.8

36.0

544

3044

UJH02

NOMESCO Finland

Anoscopy

1.6

36.0

867

5494

D07AA02

ATC

hydrocortisone; topical

1.3

36.0

3146

25003

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.5

36.0

1061

7037

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.3

36.0

136

415

I34.1

ICD-10 Finland

Mitral (valve) prolapse

1.8

35.9

564

3193

R04.2

ICD-10 Finland

Haemoptysis

1.7

35.8

709

4281

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.4

35.8

1409

9902

J01MA14

ATC

moxifloxacin; systemic

1.4

35.7

1890

13976

GD1AA, ,

SPAT

1.3

35.7

3588

29009

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

35.7

2031

15193

A13

ICPC

Concern/fear medical treatment

1.9

35.7

472

2535

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.5

35.6

986

6450

F16

ICPC

Eyelid symptom/complaint

1.5

35.6

1188

8085

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

35.5

2028

15180

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.6

35.5

957

6225

WZC00, ,

SPAT

1.3

35.5

3580

28959

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

2.8

35.5

176

628

F04

ICPC

Visual floaters/spots

3.2

35.4

140

439

3690A

ICD-9 Finland

Blindness and low vision, Profound impairment, both eyes

+∞

35.4

D82

ICPC

Teeth/gum disease

1.2

35.4

9108

80861

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

35.3

2559

19835

S08

ICPC

Skin colour change

1.5

35.3

1227

8419

S01EC03

ATC

dorzolamide; ophthalmic

2.1

35.3

317

1485

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

35.2

1298

9007

PA7DG

NOMESCO Finland

Very extended MRI examination of vessesl in brain and neck with high intensity magnet

6.4

35.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

35.2

2310

17653

F99

ICPC

Eye/adnexa disease other

2.7

35.2

189

703

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

3.2

35.2

139

436

H35.4

ICD-10 Finland

Peripheral retinal degeneration

2.7

35.2

190

709

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

35.1

1403

9888

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.6

35.0

875

5593

SPAT1255

SPAT

Intravenous administration of medicine

1.4

35.0

1426

10084

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.0

35.0

368

1829

H21.0

ICD-10 Finland

Hyphaema

3.6

34.9

116

326

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.4

34.9

234

969

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

34.8

1786

13139

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

34.8

880

5640

UJD02

NOMESCO Finland

Gastroscopy

1.5

34.8

1002

6612

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

34.8

1198

8204

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

3.2

34.8

138

434

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.6

34.7

726

4444

N05BE01

ATC

buspirone; oral

1.7

34.7

599

3485

Z90.0

ICD-10 Finland

Acquired absence of part of head and neck

5.6

34.7

116

SPAT1172

SPAT

Guidance concerning hydration

1.8

34.6

512

2848

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

34.6

2644

20643

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.5

34.6

212

842

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.7

34.5

183

676

H3601, E103,

ICD-10 Finland

2.5

34.5

209

825

R1260

NOMESCO Finland

Evaluation of communicative skills

2.1

34.5

341

1657

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

34.4

1431

10156

DFF59

NOMESCO Finland

Other assessment of balance

2.4

34.4

231

957

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

34.4

6920

60108

U04

ICPC

Incontinence urine

1.5

34.3

1306

9117

S10

ICPC

Boil/carbuncle

1.5

34.3

1307

9126

F61.0

ICD-10 Finland

Mixed personality disorders

2.0

34.3

351

1727

H26.9

ICD-10 Finland

Cataract, unspecified

2.0

34.3

373

1876

N06AX05

ATC

trazodone; oral

1.8

34.3

522

2929

N06BA04

ATC

methylphenidate; oral

1.6

34.2

724

4447

D10

ICPC

Vomiting

1.4

34.2

1334

9358

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

34.2

6949

60409

EB1AA, ,

SPAT

1.4

34.1

1381

9753

K03.80

ICD-10 Finland

Irradiated enamel

1.5

34.0

1207

8315

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

34.0

2762

21737

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

34.0

677

4094

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.5

33.9

964

6343

WX882

NOMESCO Finland

High dependency care

1.7

33.9

621

3672

R06AE09

ATC

levocetirizine; oral

1.3

33.9

3132

25056

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

33.8

1532

11038

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.7

33.7

106

287

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

33.6

1095

7415

A10AB01

ATC

insulin (human); parenteral

1.7

33.5

677

4109

UDM02

NOMESCO Finland

Sinoscopy

1.8

33.5

467

2552

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

33.4

2435

18880

SPAT1262

SPAT

Handing over of treatment supplies

1.3

33.4

3786

31028

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

33.3

1455

10415

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

1.9

33.3

399

2076

F80.1

ICD-10 Finland

Expressive language disorder

2.4

33.2

220

906

S70.0

ICD-10 Finland

Contusion of hip

1.6

33.1

853

5491

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.3

33.1

2024

15302

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.5

33.1

199

783

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.6

33.1

717

4430

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

33.1

385

1983

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.7

33.1

638

3826

R15

ICD-10 Finland

Faecal incontinence

1.7

33.0

632

3783

Angiography of the heart and coronary arteries

1.5

33.0

1155

7936

N05AX08

ATC

risperidone; systemic

1.4

33.0

1820

13548

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.6

32.9

835

5356

H3603, E113,

ICD-10 Finland

2.6

32.9

188

722

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

32.9

5208

44202

I49.5

ICD-10 Finland

Sick sinus syndrome

1.6

32.8

801

5092

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.9

32.8

441

2381

A10AB04

ATC

insulin lispro; parenteral

1.7

32.8

615

3660

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

2.5

32.7

206

829

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

32.7

1526

11053

M01AB55

ATC

diclofenac, combinations; oral

1.4

32.6

1371

9748

AA5PD

NOMESCO Finland

CT examination of brain pefusion

2.4

32.6

224

938

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

32.6

1075

7298

N06

ICPC

Sensation disturbance other

2.3

32.6

256

1136

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

32.6

1061

7185

N02CC04

ATC

rizatriptan; oral

1.5

32.5

1138

7817

K02

ICPC

Pressure/tightness of heart

1.8

32.5

502

2830

J01DC02

ATC

cefuroxime; systemic

1.5

32.4

1135

7798

N03

ICPC

Pain face

2.4

32.3

227

960

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.8

32.3

464

2558

H66.9

ICD-10 Finland

Otitis media, unspecified

1.4

32.3

1482

10700

N88

ICPC

Epilepsy

2.8

32.3

164

593

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.8

32.2

507

2873

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

32.2

4212

35047

K03.00

ICD-10 Finland

Approximal wear

1.4

32.2

1695

12520

H49.9

ICD-10 Finland

Paralytic strabismus, unspecified

12.9

32.2

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

32.2

1163

8039

SPAT1058

SPAT

PEF monitoring instruction

1.4

32.2

1734

12857

B02.9

ICD-10 Finland

Zoster without complication

1.4

32.1

1502

10879

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

1.7

32.1

612

3658

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.9

32.1

411

2185

H81.0

ICD-10 Finland

Ménière disease

1.8

32.1

502

2840

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

32.1

1244

8717

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

32.0

1245

8728

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

32.0

1085

7408

G40

ICD-10 Finland

Epilepsy

2.4

31.9

209

857

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

31.8

1199

8354

E000006, ,

ATC

1.4

31.8

1433

10313

N19

ICPC

Speech disorder

2.1

31.8

310

1499

J01FA01

ATC

erythromycin; systemic

1.3

31.8

2943

23539

SPAT1283

SPAT

Restricted health certificate

1.2

31.8

3715

30535

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

31.8

5350

45655

A02BA04

ATC

nizatidine; systemic

1.4

31.7

1513

10996

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

31.6

627

3788

XA402

NOMESCO Finland

ENMG

1.8

31.5

502

2855

L19

ICPC

Muscle symptom/complaint NOS

1.6

31.5

653

3991

P25

ICPC

Phase of life problem adult

1.5

31.5

935

6213

C10AC01

ATC

colestyramine; oral

1.7

31.4

601

3596

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

5.1

31.4

127

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

31.4

1613

11866

SPAT1009

SPAT

Measurement of intraocular pressure

2.1

31.4

295

1407

A06AC51

ATC

ispaghula, combinations; oral

1.5

31.4

1028

6971

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

31.3

880

5776

C10AA04

ATC

fluvastatin; oral

1.4

31.3

1762

13151

H16.9

ICD-10 Finland

Keratitis, unspecified

1.9

31.3

374

1944

D68.8

ICD-10 Finland

Other specified coagulation defects

2.2

31.2

251

1125

CG2T4

NOMESCO Finland

Topography assessment of cornea

2.4

31.2

205

842

L04AA52

ATC

[U] ofatumumab; parenteral

9.7

31.1

N06AB05

ATC

paroxetine; oral

1.4

31.1

1204

8432

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.5

31.1

923

6131

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

31.1

2193

16923

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

31.1

2140

16458

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

3.1

31.1

129

417

K99

ICPC

Cardiovascular disease other

1.7

31.1

558

3283

R01AD11

ATC

triamcinolone; nasal

1.4

31.1

1793

13437

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.6

31.0

725

4563

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.7

31.0

552

3240

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

31.0

1272

9005

-50

ICPC

Medication/prescr/renewal

1.6

31.0

829

5385

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.5

31.0

1083

7440

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2.1

30.9

309

1508

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.7

30.9

636

3879

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.6

30.9

173

658

D07AB08

ATC

desonide; topical

1.3

30.9

2361

18421

S01BA01

ATC

dexamethasone; ophthalmic

1.6

30.9

708

4436

181

Kela drug reimbursment

Retigabine and vigabatrin

7.5

30.9

I63

ICD-10 Finland

Cerebral infarction

2.5

30.8

185

728

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

5.6

30.8

104

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

5.2

30.8

122

SPAT1101

SPAT

Orthostatic test

1.5

30.8

884

5832

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

30.7

611

3696

S09.9

ICD-10 Finland

Unspecified injury of head

2.0

30.6

348

1778

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.5

30.6

830

5406

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.2

30.6

122

385

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

30.6

983

6638

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

30.5

24372

235094

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.8

30.5

494

2823

N06AG02

ATC

moclobemide; oral

1.5

30.5

867

5706

H3603, E106,

ICD-10 Finland

6.0

30.5

R03AC13

ATC

formoterol; inhalant

1.5

30.4

1023

6972

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.5

30.4

843

5518

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

4.5

30.4

162

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.0

30.3

312

1539

T74.1

ICD-10 Finland

Physical abuse

1.9

30.3

382

2021

R04

ICPC

Breathing problem other

1.5

30.3

844

5531

N03AB02

ATC

phenytoin; systemic

2.3

30.2

227

989

CHC05

NOMESCO Finland

Iridotomy

2.0

30.2

339

1726

SPAT1360

SPAT

Extensive global examination

1.4

30.1

1510

11064

N99

ICPC

Neurological disease other

2.1

30.1

282

1344

R49.01

ICD-10 Finland

Functional dysphonia

1.7

30.1

610

3707

F27

ICPC

Fear of eye disease

2.3

30.0

235

1042

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.6

30.0

669

4163

N80

ICPC

Head injury other

1.8

30.0

465

2624

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

30.0

4670

39525

SPAT1252

SPAT

Overall medication plan or its review

1.4

29.9

1409

10216

Z50.1

ICD-10 Finland

Other physical therapy

1.5

29.9

1101

7637

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.1

29.9

289

1393

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

6.1

29.9

K04.09

ICD-10 Finland

Pulpit UNS

1.5

29.8

943

6348

H82

ICPC

Vertiginous syndrome

1.9

29.8

390

2089

J01CF05

ATC

flucloxacillin; systemic

1.4

29.8

1526

11219

N06AA12

ATC

doxepin; systemic

1.5

29.8

1021

6985

J45.8

ICD-10 Finland

Mixed asthma

1.6

29.8

633

3893

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.4

29.8

1348

9709

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

29.8

1447

10549

XQ802

NOMESCO Finland

Epicutan test

1.5

29.8

826

5409

L84

ICD-10 Finland

Corns and callosities

1.6

29.7

746

4777

D01AE16

ATC

amorolfine; topical

1.3

29.7

2437

19191

Z94.0

ICD-10 Finland

Kidney transplant status

2.2

29.6

241

1086

H81.4

ICD-10 Finland

Vertigo of central origin

2.5

29.6

182

725

N02CD06

ATC

rimegepant; oral

2.8

29.5

150

543

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.7

29.5

515

3007

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.4

29.5

1397

10140

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

1.7

29.5

573

3444

B80

ICPC

Iron deficiency anaemia

1.7

29.5

581

3505

N03AG04

ATC

vigabatrin; oral

6.2

29.5

S01ED02

ATC

betaxolol; ophthalmic

2.4

29.4

209

889

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.3

29.4

1777

13406

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

29.4

1102

7672

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

29.4

1415

10299

37001

ICD-8 Finland

Refractive errors, Hypermetropia. Hyperopia

8.1

29.4

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

9.0

29.4

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

29.4

784

5090

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

9.7

29.4

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

1.9

29.3

375

1994

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.7

29.3

562

3368

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.0

29.2

302

1493

H15.1

ICD-10 Finland

Episcleritis

2.0

29.2

323

1636

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.5

29.2

816

5352

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

29.2

1058

7319

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

29.1

1033

7115

K11.2

ICD-10 Finland

Sialoadenitis

1.6

29.1

711

4522

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

29.0

992

6783

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.6

29.0

682

4300

F03

ICPC

Eye discharge

1.4

29.0

1538

11373

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.5

29.0

785

5113

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

29.0

3794

31543

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

2.1

29.0

279

1344

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

28.9

973

6632

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

28.9

700

4444

RS222, ,

NOMESCO Finland

2.1

28.9

258

1207

G04BD08

ATC

solifenacin; oral

1.4

28.9

1376

9996

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.7

28.9

565

3402

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.1

28.8

282

1366

D21

ICPC

Swallowing problem

2.0

28.8

331

1698

4AA23, ,

NOMESCO Finland

7.2

28.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

28.7

1023

7053

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

28.7

1013

6972

S01EX03, ,

ATC

1.8

28.7

393

2137

H05.2

ICD-10 Finland

Exophthalmic conditions

3.9

28.7

208

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.6

28.6

169

660

EMAK, ,

NOMESCO Finland

1.6

28.5

733

4718

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

28.5

1806

13722

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.0

28.5

291

1433

G83.4

ICD-10 Finland

Cauda equina syndrome

3.1

28.4

117

377

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

2.6

28.4

164

634

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

28.4

2230

17456

SGC10

NOMESCO Finland

Pulp capping

1.3

28.3

1765

13375

U29

ICPC

Urinary symptom/complaint other

1.6

28.3

676

4278

H35.1

ICD-10 Finland

Retinopathy of prematurity

7.1

28.3

XCH05

NOMESCO Finland

Eye pressure longterm registration

2.3

28.2

215

943

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.5

28.2

866

5794

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

28.1

1023

7084

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

28.1

732

4728

R01AD05

ATC

budesonide; nasal

1.4

28.0

1529

11354

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

28.0

1388

10151

H40.11

ICD-10 Finland

Low pressure glaucoma

1.8

28.0

452

2583

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

3.1

28.0

114

365

XF640, ,

NOMESCO Finland

1.7

27.9

530

3166

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.7

27.9

512

3031

H53.6

ICD-10 Finland

Night blindness

64.0

27.9

G91.1

ICD-10 Finland

Obstructive hydrocephalus

3.3

27.8

103

311

F32

ICD-10 Finland

Depressive episode

1.4

27.8

1159

8227

G36.0

ICD-10 Finland

Neuromyelitis optica [Devic]

8.4

27.8

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

27.8

2885

23376

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.5

27.7

761

4972

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

27.7

2385

18890

F41.00

ICD-10 Finland

Moderate panic disorder

1.9

27.7

323

1667

280

Kela drug reimbursment

Clopidogrel

2.1

27.6

276

1348

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.8

27.6

442

2519

H35.9

ICD-10 Finland

Retinal disorder, unspecified

2.8

27.6

137

490

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.9

27.6

126

431

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.7

27.5

517

3080

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

3.1

27.5

116

379

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.0

27.5

305

1547

L03AB13

ATC

peginterferon beta-1a; parenteral

6.7

27.5

H60.8

ICD-10 Finland

Other otitis externa

1.6

27.4

668

4248

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.1

27.4

248

1167

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

27.4

2034

15799

L50.0

ICD-10 Finland

Allergic urticaria

1.7

27.4

556

3381

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1.9

27.4

348

1848

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.4

27.3

1354

9901

127

Kela drug reimbursment

Transplant complication

1.9

27.3

318

1640

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

2.3

27.3

203

882

R10.0

ICD-10 Finland

Acute abdomen

1.6

27.3

697

4482

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.5

27.2

862

5806

Y94.8

ICD-10 Finland

Other leisure activity accident

1.6

27.2

576

3541

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.1

27.2

10711

97686

RD210, ,

NOMESCO Finland

1.8

27.1

373

2031

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

27.1

1103

7797

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.0

27.1

294

1480

M15

ICD-10 Finland

Polyarthrosis

1.4

27.1

1075

7565

K01

ICPC

Heart pain

2.0

27.1

292

1467

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

6.8

27.1

D16

ICPC

Rectal bleeding

1.7

27.0

545

3308

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.6

27.0

555

3385

A10AE05

ATC

insulin detemir; parenteral

1.4

27.0

1063

7468

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

2.1

27.0

250

1187

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.6

27.0

150

569

H34.9

ICD-10 Finland

Retinal vascular occlusion, unspecified

4.5

26.9

145

A03CA02

ATC

clidinium and psycholeptics; oral

1.4

26.9

1150

8201

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

2.6

26.9

151

576

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

3.3

26.9

101

308

IHZ05, ,

SPAT

1.5

26.8

955

6583

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.2

26.8

228

1047

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

2.9

26.8

121

411

S02

ICPC

Pruritus

1.5

26.7

820

5486

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

26.7

978

6778

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.6

26.7

567

3489

X15

ICPC

Vaginal symptom/complaint other

1.5

26.7

858

5798

WX702

NOMESCO Finland

Supraglottic ventilation device

1.4

26.6

1185

8509

L04AX03

ATC

methotrexate; systemic

1.3

26.6

2054

16035

R41.0

ICD-10 Finland

Disorientation, unspecified

1.6

26.6

630

3979

E87.6

ICD-10 Finland

Hypokalaemia

1.5

26.6

730

4769

E66.8

ICD-10 Finland

Other obesity

1.4

26.5

1138

8119

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.3

26.5

1681

12768

X57

ICD-10 Finland

Unspecified privation

1.7

26.5

467

2735

R08

ICPC

Nose symptom/complaint other

1.5

26.5

753

4958

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.8

26.4

413

2338

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

26.4

1864

14376

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

26.4

4401

37443

CKC20

NOMESCO Finland

Cryopexy of undetached retina

3.3

26.4

287

H01AC01

ATC

somatropin; parenteral

3.6

26.4

244

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.6

26.4

671

4311

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

3.3

26.4

292

R06

ICPC

Nose bleed/epistaxis

1.7

26.3

520

3141

F32.8

ICD-10 Finland

Other depressive episodes

1.9

26.3

338

1802

M77.4

ICD-10 Finland

Metatarsalgia

1.4

26.2

1291

9430

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

26.2

923

6349

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.5

26.2

856

5801

A10AA01, ,

ATC

1.7

26.2

472

2781

N27

ICPC

Fear of neurological disease other

1.8

26.2

370

2032

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

2.7

26.1

141

527

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

1.9

26.1

315

1644

A92

ICPC

Allergy/allergic reaction NOS

1.6

26.1

676

4359

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

26.1

1423

10566

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

2.6

26.1

154

602

K25

ICPC

Fear of hypertension

1.5

26.1

825

5555

K83

ICPC

Heart valve disease NOS

2.2

26.1

217

988

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

26.1

635

4038

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

26.1

975

6785

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

2.8

26.0

130

467

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

26.0

4804

41259

H61.2

ICD-10 Finland

Impacted cerumen

1.4

25.9

1486

11120

S06

ICPC

Rash localized

1.4

25.9

1235

8973

FN1AD

NOMESCO Finland

CT of coronary arteries

1.8

25.9

381

2119

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

25.9

5403

46895

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

2.6

25.9

152

593

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.9

25.9

339

1819

L50.9

ICD-10 Finland

Urticaria, unspecified

1.5

25.8

818

5511

L04AA40

ATC

cladribine; oral

7.2

25.8

R49.08

ICD-10 Finland

Other specified dysphonia

1.7

25.8

452

2645

A85

ICPC

Adverse effect medical agent

2.0

25.7

260

1277

B02AA02

ATC

tranexamic acid; systemic

1.2

25.7

3101

25539

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.7

25.7

470

2783

WW200, ,

SPAT

1.2

25.6

6959

61698

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.6

25.6

600

3782

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.4

25.6

1057

7492

H50.50

ICD-10 Finland

Alternating hyperphoria

5.1

25.6

104

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

25.5

657

4232

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

4.0

25.5

181

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.0

25.5

265

1314

ACC51

NOMESCO Finland

Release of median nerve

1.3

25.5

1559

11780

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.4

25.5

1142

8211

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

25.5

659

4250

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.3

25.5

185

796

J01

ICD-10 Finland

Acute sinusitis

1.4

25.5

1172

8466

XG466

NOMESCO Finland

Sleep oxymetry

1.6

25.4

579

3624

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

25.4

2754

22410

3780A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]

5.1

25.4

101

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.7

25.4

440

2567

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.5

25.3

799

5377

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

2.5

25.3

162

658

37301

ICD-8 Finland

Strabismus, Concomitans divergens

2.3

25.3

198

880

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.7

25.2

434

2526

N05AA02

ATC

levomepromazine; systemic

1.5

25.2

730

4826

S01FA01

ATC

atropine; ophthalmic

2.9

25.2

114

388

S01AD03

ATC

aciclovir; ophthalmic

1.5

25.2

702

4603

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.6

25.2

632

4049

N02CC06

ATC

eletriptan; oral

1.5

25.2

681

4437

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

25.1

1390

10345

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.7

25.1

480

2875

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.4

25.1

163

667

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023103) Potassium [Moles/volume] in Serum or Plasma

27727

253669

2.57

322.70

26.5

18.9

3.96

mmol/l

0.95

27373

248204

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3292

16376

2.13

322.08

1.4

1.3

41.53

53.46

au/ml

2.25

140

1041

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

932

2418

3.94

312.57

1.1

34.77

70.38

au/ml

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

668

1342

5.06

310.24

1.2

1.3

0.65

0.67

ratio

0.14

397

774

(3018418) pH of Serum or Plasma

11028

79703

1.61

310.24

4.9

4.3

7.40

0.23

8096

56798

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

14119

78605

2.53

307.65

2.6

2.2

163.39

209.73

u/l

3.96

13587

74090

(3013826) Glucose [Moles/volume] in Serum or Plasma

20672

152376

2.19

307.65

6.4

5.0

6.55

6.69

mmol/l

18.18

19901

143893

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17617

137498

1.70

307.65

6.8

6.5

10.97

11.54

umol/l

9.25

16774

130824

(3001604) Monocytes [#/volume] in Blood

17439

134591

1.72

307.65

7.6

6.4

0.58

e9/l

1.44

15105

115567

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

808

1628

5.07

307.65

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1901

6292

3.16

307.65

1.4

523.01

529.41

mg/l

0.13

1821

6037

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

26318

234641

2.13

307.65

6.8

5.5

1.85

1.91

mu/l

10.33

24685

218014

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

880

1796

5.01

307.65

1.2

43.91

41.32

mg/l

0.36

762

1513

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7906

49649

1.81

307.65

4.9

3.9

401.12

443.62

ng/l

0.29

5927

38469

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1632

5538

3.06

307.65

1.5

1.4

28.32

35.63

e6/l

0.29

1227

4098

(3006315) Basophils [#/volume] in Blood

17492

134954

1.73

307.65

7.6

6.4

0.04

e9/l

0.88

15140

115850

(3013650) Neutrophils [#/volume] in Blood by Automated count

18906

150513

1.71

307.65

10.6

9.7

4.10

4.14

e9/l

1.89

16483

130361

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

27522

250757

2.47

307.65

22.6

16.0

21.77

24.43

mg/l

39.45

23739

206774

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1712

5579

3.19

307.65

1.3

3.69

3.73

mmol/l

0.80

1610

5302

(3019550) Sodium [Moles/volume] in Serum or Plasma

27720

253238

2.59

307.65

26.2

18.8

139.64

139.63

mmol/l

0.20

27405

248191

(3006504) Eosinophils/Leukocytes in Blood

16106

123851

1.66

307.65

7.8

6.6

2.81

2.83

0.63

15192

116160

(3022096) Basophils/Leukocytes in Blood

16087

123852

1.66

307.65

7.9

6.6

0.68

0.43

15163

116089

(3019069) Monocytes/Leukocytes in Blood

16147

124187

1.66

307.65

7.9

6.7

8.82

8.81

0.19

15232

116541

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8593

57528

1.69

307.65

2.1

1.8

1.11

1.28

mg/l

4.57

6568

44697

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

850

1732

5.02

307.65

1.1

270.47

258.43

mg/l

0.31

766

1545

(3024561) Albumin [Mass/volume] in Serum or Plasma

15618

118569

1.67

307.65

5.5

5.1

35.96

35.65

g/l

10.50

14666

111086

(3019198) Lymphocytes [#/volume] in Blood

17680

137725

1.71

307.65

7.7

6.4

1.88

1.93

e9/l

3.13

15608

121066

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

23322

200433

1.78

307.65

5.4

4.5

14.80

14.78

pmol/l

0.73

21595

184365

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10890

77145

1.65

307.65

3.6

3.2

1349.13

1418.11

ng/l

0.79

9381

66396

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13867

97010

1.81

307.65

4.8

3.7

65.34

64.18

ng/l

0.02

9804

66665

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

17899

132664

1.89

307.65

8.7

7.2

1.21

mmol/l

0.97

15779

114416

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16398

118607

1.86

307.65

8.0

6.6

1.21

mmol/l

0.23

15269

109774

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8008

38688

2.47

307.65

2.4

2.2

29.32

29.66

5.44

7813

37606

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

912

1130

8.29

307.65

1.1

3.87

7.67

nmol/l

1.17

187

210

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1648

5611

3.05

307.65

1.5

1179.68

2395.22

e6/l

0.76

1305

4432

(3033658) Prothrombin time (PT) actual/Normal

9779

66264

1.71

307.65

4.8

4.2

90.14

89.61

1.26

9576

64805

(3037467) Urinalysis macro (dipstick) panel - Urine

21538

178872

1.75

307.65

6.0

4.7

3.01

4.15

0.26

269

(3031040) Bacteria [#/volume] in Urine by Automated count

20970

172750

1.74

307.65

6.3

4.8

1701.79

1865.36

e6/l

0.11

243

2418

(3032080) INR in Blood by Coagulation assay

16780

118898

1.95

307.65

17.7

14.7

1.27

1.25

inr

2.21

14277

99251

(42870588) Differential panel, method unspecified - Blood

12526

90266

1.67

307.65

7.4

6.4

5.13

3.99

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

23454

197282

1.92

307.65

9.7

8.2

78.22

79.49

u/l

3.94

22408

187334

(3013115) Eosinophils [#/volume] in Blood

17907

138943

1.73

307.65

7.8

6.6

0.19

e9/l

1.32

15701

121189

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

23231

190590

2.03

307.65

5.5

4.4

11.75

12.18

mm/h

4.73

21965

178267

(3018010) Neutrophils/Leukocytes in Blood

16160

124787

1.65

307.65

7.6

6.4

57.32

57.29

0.14

15481

119230

(3002030) Lymphocytes/Leukocytes in Blood

16331

127207

1.63

307.65

7.8

6.6

27.69

27.84

1.01

15567

120663

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15228

116121

1.64

307.65

2.4

2.1

97.51

96.33

pmol/l

2.23

8160

61705

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3544

17744

2.13

307.65

2.6

2.4

21.17

21.21

au/ml

0.01

305

1963

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

621

1211

5.21

298.38

1.1

1.13

1.11

u/l

0.15

257

490

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11354

84151

1.57

277.95

3.2

2.7

58.33

63.32

u/l

2.17

10534

77965

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

15243

120597

1.54

277.93

2.8

2.5

77.00

826.15

nmol/l

0.50

13824

109512

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4340

25049

1.86

273.95

2.5

2.3

369.23

382.44

nmol/l

3.42

4004

23276

(3021960) Folate [Moles/volume] in Serum or Plasma

10390

75687

1.57

273.06

1.8

1.7

20.20

20.23

nmol/l

0.07

8931

64458

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9841

71159

1.57

265.14

2.6

2.4

2.71

2.83

mg/l

6.02

8534

61506

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

296

298

10.01

259.72

1.2

1.1

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

12425

95004

1.53

258.06

4.4

3.5

1.70

2.07

e6/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6695

44363

1.66

257.63

2.2

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6629

44298

1.64

244.79

3.6

3.5

0.82

mmol/l

3.15

6218

41592

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

20136

171562

1.54

244.69

4.0

3.3

46.77

47.06

u/l

0.16

19076

161262

(3023368) Bacteria identified in Blood by Culture

9844

72646

1.53

234.74

4.8

4.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

15724

127821

1.49

234.16

3.7

3.2

114.88

120.94

ug/l

2.17

14659

119449

(3015377) Calcium [Moles/volume] in Serum or Plasma

11867

91418

1.50

228.78

3.4

3.5

2.35

2.36

mmol/l

5.39

10686

83191

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2197

10776

2.12

219.13

2.0

39.30

39.65

u/l

0.35

1963

9596

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3579

20756

1.82

218.55

2.7

2.3

7.14

7.11

ug/l

0.03

3046

18111

(3005719) IgG [Mass/volume] in Serum or Plasma

3501

20211

1.83

216.90

3.0

2.9

10.31

10.57

g/l

3.13

3214

18716

(3015736) pH of Urine

14092

113231

1.47

214.76

4.2

3.5

6.27

6.24

2.81

7644

62530

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

25576

232877

1.74

214.65

7.4

6.3

39.33

39.10

mmol/mol

3.92

24002

218083

(3002582) Erythrocytes [#/volume] in Urine

11256

86797

1.48

210.47

4.3

3.4

56.48

88.46

e6/l

2.77

8884

65838

(3018095) Leukocytes [#/volume] in Urine

12607

99531

1.46

208.13

5.1

4.0

81.30

102.10

e6/l

1.74

9237

69328

(3007164) IgA [Mass/volume] in Serum or Plasma

7589

54042

1.54

207.77

1.6

1.5

2.26

2.39

g/l

6.96

4499

33267

(3020564) Creatinine [Moles/volume] in Serum or Plasma

28111

264541

2.35

206.51

28.4

20.7

78.15

76.66

umol/l

9.32

27879

261421

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8540

62487

1.51

205.57

1.4

1.3

1.88

1.65

u/ml

0.66

2063

16913

(3035350) Ketones [Presence] in Urine by Test strip

16927

141733

1.45

202.42

4.8

4.0

6.60

3.94

estimate

0.83

3234

30137

(3030467) Casts [#/volume] in Urine by Automated count

9932

75196

1.48

201.21

4.1

3.3

0.32

0.42

e6/l

6.17

7533

54848

(3009261) Glucose [Presence] in Urine by Test strip

17007

142736

1.45

199.39

4.9

4.0

0.35

0.25

estimate

0.12

3045

28636

(36304419) Bacteria [Presence] in Urine

9496

71409

1.48

198.32

4.0

3.3

53.39

161.63

estimate

0.53

335

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5033

32923

1.64

196.72

2.0

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

16717

140075

1.44

196.12

4.8

3.9

0.00

estimate

0.41

3158

29432

(3037522) Nuclear Ab [Titer] in Serum

5540

37168

1.60

195.00

1.5

1.4

516.36

522.57

titre

0.09

1187

7975

(3023410) Appearance of Cerebral spinal fluid

795

2547

3.18

192.40

1.6

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

6386

44394

1.56

192.40

1.8

1124.14

1164.10

nmol/l

2.85

4840

33651

(3036489) Thrombin time

1976

9805

2.09

190.26

2.4

2.2

20.84

21.11

0.99

1741

8671

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

25903

238230

1.72

189.69

5.9

5.1

5.93

5.91

mmol/l

2.32

23957

219693

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

25882

238095

1.71

187.94

20.8

15.6

81.28

81.42

ml/min/173m2

0.47

24280

219128

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

27878

262639

2.13

184.66

15.5

12.0

25.68

25.83

u/l

0.59

27212

255258

(3000850) Epithelial cells [#/volume] in Urine

8080

59607

1.49

182.24

3.2

2.7

5.34

5.91

e6/l

3.95

7408

54135

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11105

87226

1.44

179.76

3.6

3.3

31.61

33.49

u/l

1.20

10528

82300

(3044640) Blood type and Crossmatch panel - Blood

10994

86222

1.44

179.33

2.8

2.5

—

(3013512) EKG study

11101

87232

1.44

179.07

4.3

3.6

0.71

0.74

0.11

209

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6620

47089

1.52

177.26

3.7

3.0

0.98

1.20

e6/l

1.63

3659

24874

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14899

123518

1.41

177.11

3.1

2.8

—

estimate

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

643

1906

3.42

176.48

1.3

1.96

2.17

mmol/l

3.70

585

1786

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8673

65259

1.46

175.49

2.7

2.4

—

(3019977) pH of Arterial blood

4628

30440

1.62

174.68

8.1

7.6

7.42

0.69

2599

16438

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6803

48806

1.51

174.45

1.4

1.3

34.67

35.15

iu/ml

0.04

1920

14741

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4618

30422

1.61

173.00

8.1

7.6

5.06

5.09

kpa

0.95

4423

29294

(3027801) Oxygen [Partial pressure] in Arterial blood

4614

30410

1.61

172.46

8.1

7.6

12.79

12.45

kpa

3.88

4422

29271

(3044889) 12 lead EKG panel

20007

175226

1.44

171.48

4.9

4.0

0.42

2157.71

1.18

354

(3003396) Base excess in Arterial blood by calculation

4579

30206

1.61

170.31

8.1

7.5

0.91

0.94

mmol/l

0.17

3788

24951

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5189

35439

1.56

165.81

6.9

5.9

1.05

mmol/l

0.55

4835

32916

(40768797) Stomach Pathology biopsy report

5236

36042

1.55

160.95

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

5131

35170

1.55

160.73

2.4

127.76

131.94

ug/g

0.26

4013

27857

(3022948) Iron [Moles/volume] in Serum or Plasma

6515

46990

1.49

160.62

2.9

2.6

12.88

13.00

umol/l

0.63

6032

43741

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4623

30970

1.58

160.09

2.1

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

8503

64951

1.43

154.26

4.7

3.8

0.35

0.27

0.26

624

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6077

43829

1.48

147.99

2.9

2.6

2.34

2.33

g/l

0.65

5575

40441

(3016502) Oxygen saturation in Arterial blood

4081

27066

1.59

146.26

8.5

7.9

95.85

95.59

1.79

3944

26152

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5657

40356

1.50

145.02

3.0

2.6

22.11

22.37

0.73

5213

37453

(3013247) Albumin in CSF/Albumin in Serum or Plasma

269

475

5.70

144.08

1.1

6.98

6.86

mg/g

0.05

257

455

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5980

43224

1.48

143.36

3.8

3.1

3.23

3.04

e6/l

0.59

2991

20910

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

705

2498

2.86

142.69

1.6

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

24982

230987

1.53

141.14

4.8

4.2

1.29

1.27

mmol/l

2.20

23103

213149

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3819

25234

1.59

138.42

9.0

8.3

121.51

120.69

g/l

1.76

3722

24680

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6185

45265

1.46

138.39

1.4

1.3

10.08

11.62

u/ml

0.89

2121

17662

(3014111) Lactate [Moles/volume] in Serum or Plasma

3663

24005

1.60

137.39

8.5

7.5

1.28

1.35

mmol/l

3.83

3588

23536

(3007461) Platelets [#/volume] in Blood

28384

271957

2.18

135.91

34.1

24.4

251.22

252.75

e9/l

3.53

28013

266290

(3010813) Leukocytes [#/volume] in Blood

28392

272094

2.18

135.35

34.1

24.4

6.81

6.76

e9/l

2.69

27932

265494

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

28388

272048

2.18

135.23

34.8

24.8

40.09

40.53

6.94

28198

269111

(3035941) MCH [Entitic mass]

28386

272029

2.17

135.09

33.9

24.3

30.28

30.27

0.21

28204

269184

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

597

1989

3.04

134.96

2.9

2.5

18.04

19.74

nmol/l

3.41

577

1877

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

26410

247759

1.63

134.87

6.6

5.7

2.60

2.70

mmol/l

68.08

24752

231224

(3024731) MCV [Entitic mean volume] in Red Blood Cells

28385

272032

2.17

134.80

33.9

24.3

91.05

90.98

1.56

28204

269186

(3026361) Erythrocytes [#/volume] in Blood

28386

272058

2.17

134.57

34.0

24.3

4.46

4.47

e12/l

7.37

27929

265456

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

150

147

10.24

134.18

1.1

—

(40758558) Short blood count panel - Blood

9936

79403

1.38

133.73

7.1

6.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

28386

272111

2.17

133.62

34.3

24.5

133.83

134.49

g/l

12.27

28199

269343

(3019225) pH of Specimen

3710

24553

1.58

133.13

5.0

4.2

7.37

7.36

2.30

2686

17474

(36660697) Celiac disease serology panel - Serum

3389

21996

1.61

131.95

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

26082

244185

1.59

131.59

5.8

5.0

4.49

4.63

mmol/l

82.37

24475

228740

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

25921

242674

1.56

126.90

5.7

4.9

1.44

1.47

mmol/l

22.34

24217

226038

(3014051) Protein [Presence] in Urine by Test strip

9496

75828

1.37

126.59

3.5

3.0

0.06

0.07

0.18

149

1805

(3026782) Osmolality of Urine

6763

51030

1.42

126.38

3.3

3.0

526.24

529.90

mosm/kgh2o

0.69

6012

44675

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3073

19683

1.62

125.94

1.8

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6949

52724

1.41

125.73

2.9

3.0

2.44

2.45

mmol/l

7.05

6184

47204

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2620

16120

1.68

125.69

1.9

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3759

25309

1.55

124.40

2.9

2.5

44.32

47.02

u/l

0.10

3191

21419

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4452

31096

1.51

124.21

4.2

4.4

238.37

244.17

u/l

1.50

4189

29521

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1708

9394

1.87

120.46

2.3

2.2

301.30

587.50

ug/l

7.47

1618

8861

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4387

30754

1.50

119.82

2.8

7.21

8.60

umol/l

4.72

3792

26799

(3020630) Protein [Mass/volume] in Serum or Plasma

3355

22245

1.57

118.38

2.6

66.40

66.26

g/l

0.49

3056

20323

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1937

11148

1.79

117.71

1.5

1.6

11.97

14.44

iu/ml

0.28

280

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

191

296

6.48

116.81

2.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1532

8247

1.90

115.38

2.7

2.5

96.01

92.70

7.15

1464

7932

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

891

3929

2.30

114.32

1.3

1.2

4.17

3.74

u/ml

0.28

382

1463

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3955

27403

1.51

113.75

5.2

4.0

5.85

5.82

kpa

1.07

3861

26757

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

870

3815

2.32

113.09

1.3

1.2

4.30

3.79

u/ml

0.42

450

1754

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3125

20646

1.57

111.56

4.3

3.9

88.93

89.29

ng/l

0.07

2753

17806

(3012544) pH of Venous blood

3983

27745

1.50

111.44

5.2

4.0

7.38

0.07

2297

16056

(3000991) Gas panel - Venous blood

3484

23641

1.54

110.25

10.2

8.7

—

(3002032) Base excess in Venous blood by calculation

3844

26710

1.50

108.62

5.3

4.0

1.78

1.79

mmol/l

0.03

3430

23448

(3028026) IgM [Mass/volume] in Serum or Plasma

2519

15901

1.64

108.61

2.1

1.9

1.25

1.33

g/l

0.89

2311

14633

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1490

8106

1.88

108.48

1.9

1.7

0.23

g/l

0.37

1426

7726

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1428

7665

1.90

108.36

2.9

2.6

181.38

191.75

4.53

1360

7278

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1522

8348

1.87

108.00

1.9

1.7

1.20

1.19

g/l

1.07

1464

7988

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2672

17182

1.61

106.74

3.6

3.5

4.45

4.49

pmol/l

1.03

2416

15415

(3020779) Urea [Moles/volume] in Serum or Plasma

3493

23914

1.52

105.72

8.6

7.3

9.40

9.91

mmol/l

4.00

3312

22852

(3009508) Creatinine [Moles/volume] in Urine

10865

90339

1.32

104.71

3.8

3.5

7.36

7.45

mmol/l

1.36

9168

76622

(3027945) Reticulocytes/Erythrocytes in Blood

4348

31174

1.46

104.59

2.6

1.77

0.11

3843

27759

(3026493) Urate [Moles/volume] in Serum or Plasma

8479

68056

1.34

104.31

3.0

2.7

337.23

340.27

umol/l

1.89

7375

59965

(3000494) Fungus identified in Specimen by Culture

4387

31594

1.45

102.92

1.6

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2463

15664

1.62

102.78

9.8

9.5

24.28

24.29

mmol/l

0.05

2397

15300

(3024354) Oxygen [Partial pressure] in Venous blood

3333

22918

1.51

98.29

4.5

3.4

4.58

4.54

kpa

0.67

3250

22319

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12350

105108

1.30

98.10

2.0

1.9

1.35

1.34

mmol/l

0.30

10561

88348

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1649

9542

1.77

97.86

1.3

—

(4268621) Lupus anticoagulant assay

658

2725

2.44

97.27

2.4

2.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2748

18162

1.56

97.14

9.8

8.1

24.79

24.80

mmol/l

0.09

2732

18019

(3019150) Specific gravity of Urine by Refractometry

7801

62427

1.34

96.23

5.0

4.1

1.02

1.17

kg/l

1.86

5411

41105

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1284

6919

1.89

96.08

2.1

11.92

11.52

mg/l

0.48

1192

6470

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1752

10386

1.73

95.43

1.3

0.74

0.89

u/ml

0.23

139

828

(3005322) IgE [Units/volume] in Serum or Plasma

2636

17349

1.57

94.79

1.4

1.3

236.81

239.69

u/ml

0.04

2452

16136

(3023520) Reticulocytes [#/volume] in Blood

3441

23994

1.49

94.52

2.5

2.6

68.97

69.39

e9/l

0.28

2562

17560

(3023420) DNA double strand Ab [Units/volume] in Serum

1846

11142

1.70

94.11

2.0

1.8

8.79

7.19

iu/ml

1.06

429

2629

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2702

17921

1.56

93.86

4.6

3.9

5.13

5.14

kpa

0.32

2558

17093

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2992

20309

1.52

93.49

3.4

3.0

182.26

205.98

ng/l

2.53

2732

18632

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

416

1393

3.01

93.25

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

340

1011

3.39

92.91

1.1

679.80

357.50

ng/l

0.47

283

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

782

3560

2.23

92.87

1.1

119.59

117.23

1.18

721

3220

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1343

7422

1.85

92.78

1.4

1.5

19.55

14.30

iu/ml

0.38

172

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

393

1287

3.08

91.58

1.6

—

(3045414) Leukocytes [Presence] in Urine

3619

25659

1.47

91.12

2.4

2.1

0.02

estimate

0.34

620

5193

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2331

15056

1.59

90.71

10.3

9.7

16.15

15.98

2.24

2240

14558

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2359

15304

1.59

90.07

4.5

3.8

1.45

1.78

mmol/l

4.23

1712

11260

(3042936) Bacteria identified in Isolate by Culture

4981

37514

1.39

89.51

2.2

2.0

—

(3009343) pH of Capillary blood

2620

17440

1.55

89.33

4.7

3.9

7.41

7.42

2.11

2216

14486

(4195642) Thrombophilia screening test

773

3570

2.19

88.59

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2461

16186

1.57

88.47

5.5

4.2

24.30

24.20

mmol/l

1.04

2436

15984

(3014148) Varicella zoster virus Ab [Titer] in Serum

757

3475

2.21

88.07

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2582

17238

1.54

86.73

10.3

9.6

94.08

93.94

0.52

2575

17183

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2130

13607

1.61

86.65

1.1

25.98

6.17

u/ml

0.61

142

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4021

29367

1.43

85.92

8.5

6.9

—

(3021589) Normoblasts [#/volume] in Blood

13473

117401

1.27

83.56

13.4

11.6

0.00

e9/l

0.79

10843

95671

(3012516) Albumin [Mass/volume] in Urine

9925

83295

1.29

83.50

3.7

3.5

48.52

48.63

mg/l

0.01

6281

52836

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2560

17218

1.53

82.94

10.3

9.5

1.32

0.03

2550

17119

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2906

20087

1.49

82.61

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2492

16680

1.54

82.53

10.5

9.7

0.64

0.27

2484

16591

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6803

54438

1.32

81.25

1.7

40431617.43

31400217.00

pmol/l

0.51

5659

45150

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1558

9355

1.70

80.66

2.1

1.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1435

8442

1.73

80.02

1.6

1.5

11.43

7.48

iu/ml

0.18

249

1629

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1603

9728

1.68

79.73

5.2

4.2

24.57

24.81

mmol/l

2.71

1468

8977

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

352

1174

3.02

79.51

1.3

1.2

57.85

65.48

0.69

128

(3017732) Neutrophils [#/volume] in Blood

4419

33245

1.39

78.81

3.3

3.1

4.50

4.56

e9/l

0.17

3667

28737

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2393

16032

1.53

78.75

7.3

6.7

24.59

24.50

mmol/l

0.57

2284

15375

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

455

1756

2.61

78.06

2.6

234.03

228.61

e6/l

0.22

385

1467

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1287

7394

1.77

77.96

2.2

2.0

4.06

9.60

iu/l

1.14

520

3009

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

773

3753

2.09

77.86

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

365

1260

2.92

77.55

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1557

9444

1.68

77.55

2.2

1.7

333.63

305.61

mu/l

0.72

1432

8562

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1382

8136

1.73

76.82

1.3

33.96

41.32

u/ml

0.42

439

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1647

10171

1.65

76.53

2.2

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

10014

84878

1.27

75.65

4.4

4.2

8.66

8.75

mg/mmol

0.06

6151

52620

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

599

2718

2.23

71.71

1.1

96.57

95.63

0.37

569

2541

(3011412) CD3 cells [#/volume] in Blood

552

2425

2.30

71.41

2.5

2.4

1290.63

1214.49

e6/l

0.75

478

2111

(3004119) Hemoglobin [Mass/volume] in Venous blood

2398

16413

1.50

70.98

4.5

3.4

129.75

128.76

g/l

1.40

2314

15969

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12158

105933

1.25

70.98

4.8

3.9

1.10

0.47

estimate

0.83

2646

24134

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1306

7750

1.71

70.44

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

4104

31068

1.37

69.56

1.8

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

6250

50380

1.30

68.81

2.1

2.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1354

8184

1.68

68.18

3.3

2.7

3.48

3.58

g/l

1.98

1295

7832

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1155

6688

1.75

67.97

1.3

22.90

11.35

u/ml

0.42

(3022145) Colonoscopy Study observation

3994

30210

1.37

67.90

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1686

10805

1.59

67.16

2.3

3.58

3.73

g/l

4.16

1522

9810

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1273

7604

1.70

66.98

1.3

8.56

7.72

u/ml

0.19

173

1123

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

426

1719

2.50

66.67

2.6

2.5

499.76

543.66

e6/l

0.74

346

1363

(3009466) Valproate [Moles/volume] in Serum or Plasma

706

3511

2.03

66.62

4.9

5.3

360.42

360.19

umol/l

0.01

623

3053

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1686

10828

1.59

66.54

2.3

4.20

4.23

g/l

0.66

1524

9832

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1687

10845

1.59

66.30

2.3

7.29

7.41

g/l

2.39

1524

9835

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3996

30351

1.36

66.00

5.4

4.9

33.30

32.66

3.01

2801

20356

(3047181) Lactate [Moles/volume] in Blood

1282

7708

1.69

65.81

5.9

5.5

1.27

1.31

mmol/l

0.81

1149

6836

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1604

10225

1.60

65.30

2.3

2.84

2.91

g/l

2.03

1441

9215

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1267

7620

1.69

64.96

1.3

11.85

5.12

u/ml

1.08

119

730

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1488

9341

1.62

64.53

2.3

9.92

10.14

g/l

1.14

1311

8238

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1333

8144

1.66

64.37

1.5

1.4

287.59

270.54

ug/g

1.47

757

4703

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1104

6430

1.74

63.61

1.3

5.29

4.51

u/ml

0.13

446

(3023511) Choriogonadotropin [Units/volume] in Urine

930

5168

1.82

62.87

1.5

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

9152

78031

1.25

62.39

5.1

4.1

0.00

estimate

0.80

2985

27200

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2061

14060

1.50

61.66

4.2

3.0

1.26

1.23

0.47

2047

14005

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2044

13936

1.50

61.31

4.2

3.0

0.62

0.08

2034

13897

(3045424) Erythrocytes [Presence] in Urine

1933

13035

1.51

61.12

2.4

2.1

0.01

0.16

estimate

1.06

488

4114

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2615

18724

1.43

60.88

1.3

1.2

127.51

140.42

u/ml

0.99

972

6967

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1769

11728

1.54

60.54

5.4

4.8

1.66

1.62

0.78

1664

11158

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

182

476

3.84

60.44

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

612

3014

2.05

59.33

1.7

1.8

1717.65

2473.60

titre

0.46

100

(3007930) Methemoglobin/Hemoglobin.total in Blood

1627

10692

1.55

57.88

5.6

5.1

0.89

0.88

0.72

1527

10147

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1846

12480

1.51

57.57

1.8

1.7

1.53

1.54

g/l

0.13

1586

10717

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1023

5997

1.73

57.56

1.2

43.93

44.38

u/ml

0.03

101

543

(1175426) CD3 cells/Lymphocytes in Blood

447

1972

2.28

57.32

2.2

73.46

72.41

0.72

430

1894

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

241

786

3.08

56.74

1.1

—

(3024928) Oxygen saturation in Venous blood

1109

6681

1.68

56.42

4.7

3.2

62.24

61.51

0.52

1071

6443

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3406

25807

1.36

56.40

2.4

2.3

0.21

g/l

2.16

3167

24083

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2923

21661

1.39

55.55

2.9

2.5

0.36

0.42

e6/l

1.25

2794

20713

(3052851) Hemolysis interference index of Serum or Plasma

1189

7331

1.65

55.30

3.4

3.3

2.13

2.31

index

0.39

644

3692

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1444

9340

1.57

55.06

2.4

2.5

0.75

0.84

g/l

0.39

1253

7959

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

427

1891

2.27

54.28

2.2

2.1

14.48

14.86

0.33

416

1840

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

383

1630

2.36

53.41

1.1

0.77

1.13

—

(3006245) CD3-CD19+ cells/cells in Blood

285

1056

2.71

53.17

2.5

2.4

9.01

10.80

1.35

262

991

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1125

6909

1.65

53.13

1.2

4.06

3.98

0.09

105

925

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

703

3774

1.88

53.05

1.2

19.39

15.03

u/ml

0.25

162

(3000060) B lymphocytes [#/volume] in Blood

237

798

2.98

52.81

2.3

0.51

0.37

e9/l

0.15

105

391

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

356

1479

2.42

52.40

1.7

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

796

4462

1.80

52.28

1.7

1.6

0.82

0.76

g/l

0.61

625

3470

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

202

625

3.24

51.99

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

949

5644

1.70

50.64

4.7

3.0

62.77

61.73

0.77

944

5623

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

201

632

3.19

50.40

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

665

3571

1.88

50.15

2.0

2.1

5.19

8.87

titre

0.58

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1317

8519

1.57

50.14

3.8

3.2

0.37

0.35

iu/ml

0.78

730

4690

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1258

8064

1.58

49.81

1.3

—

(3039000) Anion gap in Blood by calculation

887

5203

1.72

49.77

6.9

6.6

11.11

11.26

mmol/l

0.68

797

4706

(3018572) Chloride [Moles/volume] in Blood

887

5204

1.72

49.74

6.9

6.6

105.15

105.02

mmol/l

0.32

797

4708

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

195

608

3.22

49.59

1.1

—

(3025941) Bacteria identified in Stool by Culture

2025

14364

1.44

49.20

1.3

—

(4024509) Urine culture

1767

12234

1.47

48.76

2.2

1.9

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

196

622

3.16

48.41

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5264

43170

1.27

47.93

1.8

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

529

2679

1.99

47.51

1.5

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1222

7892

1.57

46.81

2.3

0.02

0.03

g/l

0.27

1118

7055

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1181

7570

1.58

46.74

2.3

0.00

g/l

0.95

1053

6591

(3024522) Salmonella sp identified in Specimen by Organism specific culture

620

3331

1.88

46.70

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

273

1058

2.59

46.63

2.6

2.4

55.96

51.28

umol/l

1.39

242

919

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

184

577

3.20

46.38

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

629

3406

1.86

46.23

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2626

19674

1.37

46.17

2.7

2.2

12.39

12.48

nmol/l

0.21

2359

17714

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

913

5518

1.67

45.85

6.2

5.5

554.50

1183.88

iu/ml

0.90

138

785

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

573

3019

1.91

45.83

2.0

1.7

380.58

363.22

mu/l

0.34

480

2419

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

616

3326

1.87

45.69

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1110

7075

1.59

44.99

2.4

0.00

g/l

-0.00

1052

6574

(3005988) Vibrio sp identified in Specimen by Organism specific culture

592

3174

1.88

44.89

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

590

3161

1.88

44.84

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

591

3171

1.88

44.72

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

22242

210745

1.22

44.62

28.8

20.5

332.10

332.12

g/l

0.15

22141

209527

(3013139) Helicobacter pylori Ag [Presence] in Stool

2463

18376

1.37

44.38

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1105

7067

1.58

44.14

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1110

7116

1.58

43.89

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

22236

210801

1.22

43.75

27.0

19.6

13.63

13.62

0.55

22073

208025

(42529406) Shigella sp [Presence] in Stool by Culture

1108

7130

1.57

43.10

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1191

7791

1.55

43.08

1.6

1.4

10.23

10.35

u/l

0.10

927

6255

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

398

1898

2.11

42.17

2.3

2.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1542

10692

1.46

42.11

2.7

2.3

5030.61

6102.51

u/l

0.63

531

4214

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

809

4849

1.69

41.93

1.3

1.2

75.00

154.13

titre

1.53

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

366

1694

2.17

41.88

2.7

2.5

0.75

0.71

e9/l

0.50

356

1613

(3028707) Methadone [Presence] in Urine by Screen method

778

4623

1.70

41.65

3.3

2.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

255

1013

2.53

41.45

2.4

2.2

27.80

29.24

0.94

244

966

(3020891) Body temperature

1717

12184

1.43

41.44

5.2

4.5

36.90

36.91

°c

0.18

1699

12067

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

802

4812

1.68

41.41

1.3

1.2

220.34

286.29

titre

0.47

371

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

479

2468

1.95

40.99

1.5

1.7

—

(3008898) HLA-B27 [Presence]

1324

8979

1.50

40.41

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

523

2789

1.89

40.37

1.5

1.4

6.35

6.79

g/l

2.33

401

2004

(3048929) Epstein Barr virus Ab [Presence] in Serum

1299

8802

1.50

39.80

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

521

2788

1.88

39.79

1.5

1.4

0.35

0.42

g/l

4.24

398

2005

(3028192) IgG subclass 2 [Mass/volume] in Serum

521

2789

1.88

39.75

1.5

1.4

2.91

2.92

g/l

0.03

399

2010

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1526

10683

1.45

39.59

1.8

1.7

0.28

0.30

mg/l

0.59

652

4960

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

221

839

2.64

39.44

2.5

2.7

0.99

1.21

ug/l

1.11

216

798

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1311

8927

1.49

39.21

2.8

2.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

863

5357

1.63

39.03

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

863

5357

1.63

39.03

1.3

—

(4062490) Immunoglobulin typing, IgG

511

2742

1.88

38.71

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

891

5589

1.61

38.61

1.3

69.61

45.72

u/ml

0.29

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

873

5453

1.62

38.50

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

781

4752

1.66

38.24

1.8

1.9

5.07

4.99

mmol/24h

0.18

700

4213

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

865

5408

1.62

38.00

1.4

23.17

22.81

u/ml

0.02

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

721

4307

1.69

37.87

3.4

3.0

767.67

5937.76

u/ml

1.36

253

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1318

9064

1.47

37.49

3.5

3.3

42.81

43.09

mg/l

0.02

1144

7687

(3023183) Ammonium ion [Moles/volume] in Plasma

890

5623

1.60

37.44

2.4

2.7

30.97

33.55

umol/l

3.43

802

5046

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1932

14242

1.38

37.29

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2676

20732

1.32

37.14

2.9

2.7

66.38

65.99

ml/min/173m2

0.20

1190

8723

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

512

2790

1.85

36.96

1.2

53.49

42.51

u/ml

0.47

148

(3034860) Kappa light chains.free [Mass/volume] in Serum

1316

9079

1.47

36.82

3.5

3.3

76.93

62.51

mg/l

0.19

1142

7698

(40768443) Skin Pathology biopsy report

1676

12090

1.41

36.79

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3740

30302

1.27

36.66

1.9

1.7

1.49

1.45

3.05

3262

26631

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1482

10473

1.44

36.51

2.0

1.9

2.18

2.12

ug/l

0.06

1261

9281

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

837

5245

1.61

36.43

1.3

270.09

261.09

u/ml

0.35

521

3274

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

649

3809

1.72

36.40

1.3

0.26

0.23

nmol/l

0.15

249

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8016

70295

1.19

36.12

5.7

5.6

2.86

3.20

ug/l

0.53

7203

63583

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1340

9313

1.46

36.08

3.0

24.52

24.73

mmol/l

1.31

1315

9145

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1050

6948

1.53

36.01

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1083

7228

1.52

35.68

2.4

1.9

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

437

2291

1.92

35.58

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

634

3733

1.71

35.15

1.3

3.66

1.59

nmol/l

0.44

619

3587

(3010503) CD19 cells [#/volume] in Blood

313

1462

2.15

35.09

2.6

2.5

356.81

316.01

e6/l

0.11

305

1415

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1044

6944

1.52

34.95

1.1

4.78

6.80

eliau/ml

0.94

855

(3028679) Herpes simplex virus Ab [Presence] in Serum

305

1417

2.16

34.67

1.1

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

314

1477

2.14

34.58

1.4

1.5

5.69

5.98

u/l

0.17

257

1271

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1790

13197

1.38

34.46

4.8

4.1

49.62

47.40

3.41

1768

13014

(40759836) Histone Ab [Presence] in Serum by Immunoblot

427

2248

1.91

34.35

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

420

2210

1.91

33.85

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

472

2579

1.84

33.82

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

408

2131

1.93

33.62

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1176

8080

1.47

33.59

3.3

2.93

5.75

ratio

1.07

698

4670

(3027273) Bicarbonate [Moles/volume] in Venous blood

1631

11903

1.39

33.38

4.7

3.5

25.19

25.26

mmol/l

0.37

1574

11532

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

418

2207

1.90

33.35

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

199

781

2.56

33.29

1.3

1.2

31.38

20.48

1.10

119

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

787

4969

1.60

33.22

1.5

148.70

149.00

au/ml

0.02

224

1426

(3002179) Metamyelocytes/Leukocytes in Blood

2874

22812

1.29

33.06

4.6

4.2

0.67

0.71

0.29

998

6797

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

601

3550

1.71

32.96

7.1

6.2

11.81

11.96

mg/l

0.35

556

3274

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1255

8771

1.45

32.80

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

397

2081

1.92

32.39

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

406

2147

1.90

32.25

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

558

3262

1.72

31.80

1.3

0.60

0.21

nmol/l

0.45

446

2536

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1004

6758

1.50

31.76

1.6

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

285

1343

2.13

31.30

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

570

3368

1.70

31.25

1.4

1.3

—

(3022621) pH of Urine by Test strip

2686

21340

1.28

30.55

3.0

2.6

6.07

6.08

0.48

1745

14299

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

270

3.63

30.42

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1779

13368

1.35

30.26

1.5

1.4

26.04

26.57

iu/l

0.27

1480

11427

(3041096) Erythrocytes [Presence] in Urine by Automated

8515

75919

1.17

30.17

4.0

3.4

0.27

0.25

estimate

0.07

2605

23557

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

176

686

2.57

29.92

3.0

2.07

1.86

ratio

0.91

165

626

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

303

1487

2.05

29.90

1.1

1.06

ratio

0.37

254

1232

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

677

4232

1.61

29.82

1.4

1.5

9.25

15.41

u/ml

0.76

100

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

426

2356

1.82

29.42

1.3

1.2

73.85

74.25

u/ml

0.01

(3018405) Lactate [Moles/volume] in Arterial blood

1178

8304

1.43

29.38

4.3

4.0

1.32

1.40

mmol/l

2.16

1161

8140

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

109

330

3.31

29.29

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

1266

9061

1.41

29.00

3.5

3.3

414.34

463.96

mg/l

0.28

582

4126

(3039162) Centromere protein B Ab [Units/volume] in Serum

562

3381

1.67

28.83

1.3

63.11

53.30

u/ml

0.30

213

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

819

5408

1.53

28.40

2.1

1.9

190.94

196.83

pmol/l

0.92

782

5137

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

822

5440

1.52

28.21

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

892

6014

1.50

28.01

1.5

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1057

7377

1.45

27.83

2.0

1.8

43.02

42.35

nmol/l

0.32

1027

7203

(3017181) Myelocytes/Leukocytes in Blood

2951

23973

1.26

27.75

4.8

4.4

0.96

0.93

0.17

982

7144

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1377

10076

1.38

27.68

1.6

14.95

17.71

u/ml

0.79

289

2350

(3025159) Blasts/Leukocytes in Blood

2863

23200

1.26

27.51

5.1

4.6

0.26

0.30

0.11

839

5917

(3037756) Immunofixation for Serum or Plasma

825

5507

1.51

27.20

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

343

1820

1.89

27.06

1.3

1.4

11.83

12.64

umol/l

1.36

325

1712

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

467

2726

1.72

26.83

1.2

1.1

2.20

2.03

iu/ml

0.09

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

286

1432

2.00

26.76

2.9

2.8

43.22

39.12

3.25

180

778

(3038026) Centromere Ab [Units/volume] in Serum

370

2019

1.84

26.74

1.3

1.2

43.55

57.64

u/ml

0.39

133

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

300

3.30

26.61

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

574

3556

1.62

26.28

1.4

1.3

506.87

358.83

pmol/l

0.39

490

3034

(3011985) Renin [Units/volume] in Plasma

612

3853

1.60

26.22

1.7

1.5

58.02

63.54

mu/l

0.28

560

3452

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

962

6688

1.45

25.86

1.3

—

(3014271) Vancomycin [Susceptibility]

247

1189

2.08

25.76

3.2

2.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

999

7001

1.44

25.74

1.2

—

(3045716) Anion gap in Serum or Plasma by calculation

467

2758

1.70

25.73

3.2

3.0

10.53

10.81

mmol/l

0.87

461

2723

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

692

4502

1.55

25.72

1.2

1.1

17.94

15.64

au/ml

0.31

132

1070

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3704

31082

1.22

25.57

2.4

2.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

291

1491

1.96

25.52

1.4

1.5

8.85

8.70

ug/l

0.03

272

1361

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

255

1248

2.05

25.44

3.0

2.1

162.28

125.59

umol/l

0.72

137

642

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

272

1363

2.00

25.42

1.2

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

294

1518

1.94

25.21

1.6

1.5

22.64

22.78

umol/l

0.03

274

1410

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

117

404

2.90

25.21

1.9

1.6

1.52

1.02

nmol/l

—

(3028433) Virus identified in Specimen by Culture

180

770

2.34

25.11

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3419

28520

1.22

25.01

2.3

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2012

15823

1.29

24.61

2.2

2.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

187

826

2.27

24.24

3.2

3.0

29.24

28.35

umol/l

0.37

144

628

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

5.89

24.21

1.1

0.04

0.06

mg/l

0.72

(3011048) Pyruvate [Moles/volume] in Blood

141

4.33

24.18

1.5

1.3

82.18

85.25

umol/l

0.23

130

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

885

6136

1.45

24.15

1.5

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2360

19000

1.26

23.84

2.4

2.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

258

1299

1.99

23.83

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

512

3161

1.63

23.82

2.2

2.0

24.12

26.22

mg/l

0.41

172

1147

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

326

1775

1.84

23.79

3.1

3.5

138.61

154.26

nmol/l

0.23

319

1750

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

216

1021

2.12

23.68

1.0

1.1

96.53

96.24

0.04

176

803

(3013005) Retinol [Moles/volume] in Serum or Plasma

249

1244

2.01

23.51

1.8

2.0

2.05

1.90

umol/l

1.71

229

1141

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

146

586

2.50

23.47

1.2

1.3

96.84

94.52

0.44

146

580

(3021440) Promyelocytes/Leukocytes in Blood

2794

22966

1.24

23.44

4.9

4.4

0.11

0.12

0.26

828

6174

(3028626) Oxygen [Partial pressure] in Capillary blood

1029

7375

1.41

23.40

5.1

3.9

8.50

8.36

kpa

1.87

1007

7190

(3003181) Sodium [Moles/volume] in Urine

746

5045

1.49

23.14

1.5

1.4

65.94

61.41

mmol/l

2.02

618

4000

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

247

1243

1.99

22.87

1.5

1.6

3.63

10.44

nmol/l

0.82

199

1035

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

327

1806

1.82

22.81

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

539

3416

1.59

22.52

1.6

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

329

1828

1.81

22.51

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

538

3416

1.58

22.31

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

538

3416

1.58

22.31

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

538

3417

1.58

22.28

1.6

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

512

3217

1.60

22.20

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6319

56124

1.16

22.15

4.7

4.6

22.40

22.15

0.64

3017

27877

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

197

923

2.14

22.13

1.2

1.3

0.31

0.30

g/l

0.74

153

758

(3017354) Segmented neutrophils/Leukocytes in Blood

459

2821

1.64

21.79

3.8

3.4

57.75

57.33

0.15

386

2415

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

391

2308

1.70

21.67

3.1

2.8

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

186

863

2.16

21.44

1.2

111.98

109.63

0.58

169

777

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

194

918

2.12

21.27

1.1

—

(3034426) Prothrombin time (PT)

172

776

2.22

21.26

1.3

1.2

28.53

28.06

0.34

172

776

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

736

5074

1.46

20.75

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

351

2038

1.73

20.69

1.3

1.15

2.17

u/ml

1.76

219

1189

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

297

3.00

20.47

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

282

3.05

20.39

2.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

458

2863

1.61

20.33

2.4

2.5

17.98

27.35

iu/ml

2.42

279

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

184

869

2.12

20.30

1.5

1.4

612.79

715.82

mu/l

0.25

177

829

(3008295) Osmolality of Serum or Plasma

465

2919

1.60

20.28

1.5

281.72

278.02

mosm/kgh2o

2.72

350

2206

(3026250) Tacrolimus [Mass/volume] in Blood

222

1124

1.98

20.27

50.7

39.8

7.24

7.17

ug/l

0.22

207

1011

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

599

3984

1.51

20.20

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

727

5027

1.46

20.19

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

651

4408

1.49

20.12

1.2

1.3

31.65

34.08

u/l

0.21

569

3823

(3026389) Candida sp identified in Specimen by Organism specific culture

610

4079

1.50

20.05

1.5

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

219

1109

1.98

20.00

1.2

1.1

7.70

12.47

u/ml

0.46

119

(3020191) Ethanol [Moles/volume] in Serum or Plasma

360

2129

1.70

19.87

1.8

1.4

1.14

1.22

promille

0.48

292

1654

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

185

884

2.10

19.81

1.5

1.4

74.11

72.98

0.69

178

844

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

163

742

2.20

19.75

1.3

159.95

125.50

nmol/l

0.96

120

529

(3033923) Metanephrine [Moles/time] in 24 hour Urine

120

480

2.50

19.53

1.1

12.30

0.80

umol/24h

0.49

226

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

671

4599

1.47

19.52

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1107

8280

1.35

19.39

4.7

4.1

1.56

1.53

mg/l

0.56

1008

7574

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

240

3.17

19.23

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

585

3914

1.50

19.20

1.4

25.81

27.56

u/l

0.62

482

3199

(3051611) Lipemic interference index of Serum or Plasma

424

2640

1.61

19.16

3.8

3.4

14.45

14.10

index

0.14

276

1462

(4094501) Cardiovascular stress test using bicycle ergometer

936

6840

1.38

19.01

1.1

—

(4146454) Self-monitoring of blood glucose

432

2714

1.60

18.82

2.9

2.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

275

2.98

18.74

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

428

2688

1.60

18.68

3.8

3.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

187

918

2.04

18.66

1.4

1.2

0.25

0.60

g/l

1.21

(3003129) Base excess in Capillary blood by calculation

476

3068

1.56

18.58

2.3

0.19

0.60

mmol/l

1.37

449

2938

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

241

1294

1.87

18.52

1.6

2.0

151.29

147.12

0.35

228

1216

(3004716) Salmonella sp identified in Stool by Organism specific culture

1614

12792

1.28

18.50

1.3

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

267

1484

1.80

18.36

2.7

2.0

—

(3044927) Protein electrophoresis panel - Urine

398

2468

1.62

18.31

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

640

4402

1.46

18.31

1.1

—

(3016228) CD19 cells/cells in Blood

191

952

2.01

18.29

2.0

8.51

8.32

0.07

186

926

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

225

1190

1.90

18.12

2.4

2.3

—

(3004809) Band form neutrophils/Leukocytes in Blood

633

4357

1.46

18.05

3.7

3.4

1.44

1.55

0.35

554

3906

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

112

4.20

17.99

5.9

4.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1646

13122

1.27

17.98

1.1

183.05

187.05

titre

0.03

352

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

356

2169

1.65

17.60

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

356

2169

1.65

17.60

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

356

2169

1.65

17.60

1.5

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

227

1219

1.87

17.47

1.2

1.1

2.92

3.76

iu/ml

0.50

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

602

4134

1.46

17.39

1.2

0.67

0.97

0.62

140

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

639

4443

1.45

17.30

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

361

2.63

17.23

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

157

3.57

17.12

1.1

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

318

1897

1.68

17.07

1.2

1.3

77.41

80.40

0.17

138

(21494755) Public health laboratory ask at order entry panel

1872

22750

0.81

16.68

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

248

1393

1.78

16.52

1.1

—

(4035726) Immunohistochemistry procedure

2706

22936

1.20

16.41

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

441

2880

1.54

16.29

3.1

3.5

6.42

10.28

nmol/l

0.62

425

2787

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

158

768

2.06

16.27

1.1

7.27

4.92

u/ml

0.34

(3017704) Immunofixation for Urine

241

1349

1.79

16.25

1.8

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

257

2.88

15.96

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3200

27586

1.18

15.93

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

264

2.84

15.79

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

816

6014

1.37

15.78

3.8

3.4

—

302.87

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

252

1443

1.75

15.74

13.5

13.4

0.59

0.62

mmol/l

0.89

225

1343

(3016879) Cocaine [Presence] in Urine

1308

10306

1.28

15.73

2.8

2.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

216

1185

1.83

15.59

1.7

1.9

28.89

28.55

umol/l

0.20

204

1116

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

172

876

1.97

15.58

1.2

1.1

88.58

90.19

0.29

398

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

148

3.51

15.58

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

544

3748

1.46

15.51

1.1

3.05

2.67

0.26

602

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

411

2676

1.54

15.43

1.1

—

(3018133) Calcium [Moles/volume] in Urine

125

567

2.21

15.40

1.9

2.0

2.77

2.67

mmol/l

0.20

114

518

(3036603) Volume of Urine

317

1944

1.64

15.35

1.7

1.6

2075.68

1953.63

0.74

311

1896

(3000093) Morphology [Interpretation] in Blood Narrative

396

2563

1.55

15.27

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

982

7479

1.32

15.26

1.2

959.63

942.37

titre

0.02

215

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

287

1724

1.67

15.08

1.3

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

102

429

2.38

15.01

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

985

7529

1.32

14.93

1.8

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

248

1438

1.73

14.85

1.5

1.6

1.17

1.24

nmol/l

0.43

175

1088

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

168

864

1.95

14.82

1.3

1.1

86.21

90.52

0.58

400

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

171

888

1.93

14.67

1.5

1.4

14.45

15.10

pmol/l

0.93

144

738

(4198724) Urine methamphetamine measurement

208

1151

1.81

14.63

3.5

2.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

177

931

1.90

14.61

1.6

1.9

39740.84

24794.19

u/ml

0.15

134

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

150

3.40

14.56

1.1

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

491

3363

1.47

14.46

1.6

1.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

419

2782

1.51

14.40

1.2

30.00

33.48

nmol/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

281

1700

1.66

14.39

1.3

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

442

2972

1.49

14.29

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

172

905

1.90

14.20

1.2

112.31

107.70

0.76

159

824

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

228

1310

1.74

14.13

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

228

1310

1.74

14.13

1.6

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

228

1310

1.74

14.13

1.6

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

227

1312

1.73

13.80

1.6

1.8

—

(3028271) Lactate [Moles/volume] in Capillary blood

576

4101

1.41

13.78

2.1

1.8

1.68

1.72

mmol/l

0.45

562

3995

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

127

3.54

13.69

1.0

1.1

2.86

2.95

u/l

—

(3003694) ABO and Rh group [Type] in Blood

8264

76524

1.11

13.55

1.5

—

(3023419) Bacteria identified in Sputum by Culture

478

3302

1.45

13.51

2.8

2.6

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

311

2.54

13.45

1.6

1.2

62.87

48.22

1.87

147

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

343

2215

1.55

13.43

1.2

113.45

110.17

pmol/l

0.34

343

2215

(43055514) Macroprolactin [Presence] in Serum or Plasma

134

660

2.03

13.41

1.5

1.4

—

(3010421) pH of Blood

1068

8382

1.28

13.30

3.9

3.6

7.41

1.54

1055

8255

(3000764) Benzodiazepines [Presence] in Urine

1368

11058

1.25

13.28

2.7

1.9

—

(3021901) Oxygen saturation in Capillary blood

753

5639

1.34

13.20

3.1

3.0

90.56

90.07

1.20

736

5487

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

411

2.31

13.18

6.4

6.2

5726.00

8906.43

iu/ml

—

(3022806) Fractional oxyhemoglobin in Capillary blood

451

3101

1.46

13.08

2.0

1.8

90.17

89.84

0.54

446

3053

(3016244) Insulin [Units/volume] in Serum or Plasma

278

1721

1.62

13.05

3.1

23.39

25.39

mu/l

0.53

263

1624

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

334

2164

1.55

12.91

1.2

236.67

144.58

titre

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

777

5869

1.33

12.86

1.1

1.34

2.08

u/ml

2.12

444

3182

(3007566) Smooth muscle Ab [Titer] in Serum

974

7592

1.29

12.81

1.2

1.3

113.63

126.62

titre

0.27

743

(3002079) Sodium [Moles/time] in 24 hour Urine

207

1192

1.74

12.79

1.3

1.2

148.29

159.40

mmol/24h

1.24

207

1192

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

334

2169

1.54

12.78

1.2

205.62

190.92

titre

0.10

370

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

138

3.33

12.78

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

743

5586

1.34

12.70

2.8

2.6

16.73

16.40

2.11

726

5471

(40768446) Kidney Pathology biopsy report

180

997

1.81

12.70

1.9

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2456

21098

1.18

12.66

4.2

3.9

1.22

1.23

mmol/l

3.09

2179

18120

(3002256) Pathology report gross observation

3984

35471

1.14

12.66

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

165

891

1.85

12.64

1.1

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

710

5310

1.34

12.58

3.6

3.3

0.77

0.81

nmol/l

0.92

567

4278

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

335

2.42

12.46

1.6

1.9

—

(3028300) Cannabinoids [Presence] in Urine

1368

11142

1.24

12.41

2.7

1.9

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

271

1689

1.61

12.40

1.3

68.33

59.69

titre

0.20

127

(3010015) Selenium [Moles/volume] in Serum or Plasma

278

2.55

12.26

1.9

1.25

1.34

umol/l

1.22

207

(3006184) Hemoglobin [Mass/volume] in Capillary blood

858

6617

1.30

12.25

2.3

2.2

130.50

129.16

g/l

0.83

627

5140

(3020911) Cortisol [Moles/time] in 24 hour Urine

168

923

1.82

12.20

1.4

91.37

197.33

nmol/24h

1.73

168

923

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

276

1737

1.59

12.14

1.3

562.67

492.15

titre

0.07

130

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

170

939

1.81

12.13

1.6

2.0

—

(3027008) Opiates [Presence] in Urine

1362

11116

1.23

12.13

2.6

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

305

1973

1.55

11.92

1.1

9.07

7.88

iu/ml

0.31

497

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

205

1203

1.71

11.88

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

205

1203

1.71

11.88

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

225

2.71

11.87

1.1

7.70

1.71

umol/24h

0.50

225

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

476

3369

1.42

11.85

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

169

939

1.80

11.84

1.6

2.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

289

2.49

11.83

4.8

3.0

42.10

41.38

umol/l

0.10

247

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.83

11.75

1.0

1.1

—

(3024316) Viscosity of Plasma

116

3.45

11.73

1.3

1.9

1.36

1.65

mpas

2.65

(3010726) Horse dander IgE Ab [Units/volume] in Serum

639

4759

1.35

11.67

1.1

1.91

1.90

u/ml

0.01

359

2499

(3006922) Hepatitis E virus Ab [Presence] in Serum

317

2086

1.52

11.48

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

135

706

1.91

11.46

1.4

1.3

16.56

16.66

umol/l

0.09

122

607

(3012501) Base excess in Blood by calculation

725

5520

1.32

11.40

4.2

4.0

2.23

2.56

mmol/l

3.08

490

3716

(3027315) Oxygen [Partial pressure] in Blood

729

5555

1.32

11.40

4.1

4.0

8.75

8.63

kpa

1.08

715

5416

(3013290) Carbon dioxide [Partial pressure] in Blood

725

5522

1.32

11.37

4.2

4.0

5.01

5.00

kpa

0.14

711

5384

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

306

2003

1.53

11.36

1.4

1.6

23.83

25.05

u/ml

0.13

384

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

445

2.16

11.35

1.2

1.5

660.00

169228.87

u/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

169

956

1.77

11.18

1.7

2.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

222

2.66

11.08

1.1

1.0

0.03

0.05

u/ml

0.90

222

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3115

27524

1.15

11.00

3.6

4.2

30.00

23.62

ug/l

0.33

2478

22339

(3027944) Amphetamines [Presence] in Urine

1334

10978

1.22

11.00

2.7

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

480

3453

1.39

10.92

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

103

500

2.06

10.83

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

248

2.54

10.82

1.2

1.3

2.20

1.60

iu/ml

1.49

134

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

163

922

1.77

10.80

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

367

2521

1.46

10.79

4.1

3.8

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

122

630

1.94

10.79

1.3

1.2

110.58

106.60

0.59

117

601

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

198

2.73

10.67

1.1

1.3

0.63

0.54

iu/ml

0.19

104

(3020876) Protein [Mass/time] in 24 hour Urine

454

3255

1.40

10.56

2.2

2.5

1.18

1.21

g/24h

0.10

246

1899

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

1.77

2.95

mg/l

1.28

145

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

2.75

4.46

mg/l

1.23

135

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

0.54

1.10

mg/l

1.22

141

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

1.79

2.01

mg/l

0.10

136

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

1.11

2.40

mg/l

2.02

157

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

0.92

1.83

mg/l

1.72

132

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

1.61

1.18

mg/l

0.27

132

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

1.50

2.62

mg/l

1.14

143

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

205

2.68

10.54

1.6

1.7

1.86

1.50

mg/l

0.29

150

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

211

2.65

10.51

1.6

1.7

0.97

1.83

mg/l

1.01

145

(3034274) Bile acid [Moles/volume] in Serum --fasting

510

3733

1.37

10.47

2.0

2.3

6.82

7.29

umol/l

0.15

376

2744

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

296

1962

1.51

10.41

1.5

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

365

2525

1.45

10.37

1.4

1.3

1.51

1.45

nmol/l

0.38

321

2277

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1079

8741

1.24

10.34

1.3

201.73

223.60

miu/ml

1.26

462

4007

(1616796) Gas panel - Central venous blood

774

6033

1.29

10.27

3.9

3.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

665

5085

1.31

10.19

1.1

3.71

5.39

u/ml

3.38

371

2730

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

669

5124

1.31

10.13

3.2

1.9

0.88

0.85

nmol/l

0.41

546

4353

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4577

41677

1.11

9.84

3.3

0.74

0.78

ug/l

1.33

3122

27527

(3008401) Mugwort IgE Ab [Units/volume] in Serum

640

4898

1.31

9.77

1.1

1.00

1.10

u/ml

0.12

304

2223

(3013637) Mi-2 Ab [Presence] in Serum

129

702

1.84

9.77

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

129

702

1.84

9.77

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

129

702

1.84

9.77

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

129

702

1.84

9.77

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

550

4126

1.34

9.66

1.1

4.97

4.13

u/ml

0.30

304

2106

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

883

7052

1.26

9.63

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

720

5610

1.29

9.61

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

310

2111

1.47

9.60

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

278

1853

1.50

9.57

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

112

588

1.91

9.49

1.3

1.1

108.65

83.02

2.67

162

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

253

1660

1.53

9.39

2.0

2.3

101.25

97.39

1.10

237

1562

(44806071) Cardiolipin IgM antibody measurement

342

2.19

9.32

1.1

—

(3016038) Potassium [Moles/volume] in Urine

276

1850

1.49

9.26

1.3

33.06

34.39

mmol/l

0.43

237

1610

(3017315) Amylase [Enzymatic activity/volume] in Urine

218

1390

1.57

9.21

1.3

1.2

178.70

338.57

u/l

4.20

200

1285

(3008536) Aspergillus sp Ab [Presence] in Serum

100

511

1.96

9.19

1.9

2.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

469

3464

1.36

9.16

1.1

0.33

0.41

u/ml

0.19

176

1105

(40757494) Bilirubin.total [Moles/volume] in Blood

202

1270

1.59

9.07

2.1

2.2

18.01

44.49

umol/l

3.29

135

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

164

2.74

9.06

1.2

1.1

9.38

31.02

2.23

(3042517) Benzodiazepines panel - Urine

308

2.24

9.04

2.8

2.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

539

4079

1.33

8.95

1.1

84.32

3365.57

iu/ml

0.66

103

834

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

174

1058

1.65

8.95

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

202

1281

1.58

8.76

1.3

—

(3042631) Mycobacterium sp identified in Specimen

456

3382

1.35

8.70

3.1

2.6

—

(3042733) HLA Ab [Presence] in Serum

139

803

1.73

8.67

5.6

4.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

514

3883

1.33

8.66

1.1

5.99

5.02

u/ml

0.35

255

1784

(3028717) Thiamine [Mass/volume] in Blood

340

2.15

8.64

1.2

65.03

62.89

ug/l

0.34

340

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

105

559

1.88

8.58

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2926

26160

1.13

8.57

3.8

3.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

830

6678

1.25

8.54

1.7

1.6

11519.42

13869.61

e6/l

1.09

599

4719

(4015189) Microbial culture of sputum

112

610

1.84

8.52

1.8

2.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

369

2659

1.39

8.44

2.1

—

(3025130) Human papilloma virus identified in Specimen

548

4195

1.31

8.42

1.7

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

554

4253

1.31

8.34

1.7

1.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

243

1626

1.50

8.28

1.3

4.99

5.05

umol/l

0.09

214

1443

(3037692) Legionella sp identified in Specimen by Organism specific culture

143

846

1.69

8.21

1.3

1.4

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.67

8.13

1.8

1.6

151.12

277.71

nmol/l

1.10

(3021788) Differential panel - Synovial fluid

643

5051

1.28

8.12

1.5

0.80

1.00

—

(3008037) Lactate [Moles/volume] in Venous blood

792

6377

1.25

8.11

3.8

3.2

1.49

1.57

mmol/l

1.64

771

6226

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

107

589

1.82

7.91

1.2

1.1

84.60

72.04

1.05

157

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

393

2896

1.36

7.86

1.2

64.89

64.56

u/l

0.01

345

2541

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1081

9021

1.20

7.83

1.9

1.7

4.16

4.32

mg/l

0.17

852

6639

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

606

1.80

7.80

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

613

4815

1.28

7.77

1.7

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.16

7.76

3.6

4.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2420

27086

0.88

7.72

1.9

3.45

ratio

0.06

1843

20592

(37208534) Antinuclear antibody arbitrary concentration in serum

151

922

1.64

7.72

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

680

8472

0.80

7.72

1.1

0.61

0.62

ratio

0.12

1018

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

390

2.00

7.71

1.9

1.3

108.96

326.72

ng/l

0.49

249

(3033099) Centromere Ab [Titer] in Serum

117

667

1.76

7.70

1.2

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

191

2.46

7.67

4.1

4.5

2.55

2.20

mg/l

0.61

160

(3010375) cycloSPORINE [Mass/volume] in Blood

173

1096

1.58

7.61

28.1

30.5

111.25

116.35

ug/l

0.48

135

919

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

169

2.54

7.53

1.8

1.3

26.67

41.35

1.33

112

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.79

7.49

1.8

1.7

286.50

304.08

nmol/l

0.04

(3027231) Wheat IgE Ab [Units/volume] in Serum

100

551

1.82

7.40

1.1

1.41

4.92

u/ml

1.01

471

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

472

3610

1.31

7.36

1.1

4.04

3.17

eliau/ml

0.41

175

1642

(3006270) Folate [Moles/volume] in Blood

280

1976

1.42

7.30

1.2

347.24

358.00

nmol/l

0.37

240

1632

(3000330) Specific gravity of Urine by Test strip

1538

13312

1.16

7.26

3.9

3.5

1.02

ratio

0.47

1387

11933

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

289

2054

1.41

7.24

1.1

292.49

290.30

mg/l

0.20

263

1867

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

111

637

1.74

7.18

13.4

7.4

6.00

5.95

kpa

0.25

564

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

138

841

1.64

7.14

3.3

3.1

4.96

4.92

kpa

0.16

138

841

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

547

4285

1.28

7.13

1.6

1.5

0.37

0.39

nmol/l

0.29

407

3284

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

354

2.01

7.10

1.7

1.8

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

314

2.07

7.09

10.8

9.3

0.40

0.42

umol/l

0.10

276

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

106

2.92

7.07

1.4

1.6

0.40

0.13

u/l

0.58

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

237

1635

1.45

7.01

1.3

1.2

22.53

25.13

u/l

0.39

198

1364

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

114

664

1.72

7.00

1.1

—

(3004451) EKG impression Narrative

219

1488

1.47

7.00

1.4

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

129

777

1.66

7.00

1.9

2.0

1.99

1.77

ratio

0.84

124

749

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

152

2.56

6.97

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

123

735

1.67

6.89

1.4

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

137

842

1.63

6.88

3.4

3.1

10.35

10.49

kpa

0.26

137

842

(3006462) Nitrate [Presence] in Urine

177

1156

1.53

6.86

3.5

3.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

117

695

1.68

6.71

1.6

1.7

0.38

0.39

ug/l

0.13

499

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

460

1.85

6.71

2.2

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

425

1.88

6.69

2.3

2.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

512

1.80

6.64

1.1

21.20

30.40

u/ml

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

326

2401

1.36

6.63

4.8

5.3

98.36

109.53

u/ml

0.14

106

811

(3024471) HLA-A [Type]

125

759

1.65

6.60

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.00

6.60

1.9

2.8

1.57

3.42

mu/l

0.86

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

239

1675

1.43

6.53

1.3

1.2

98.33

95.50

u/l

0.11

203

1427

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

113

671

1.68

6.51

1.9

28.25

38.67

u/l

0.36

614

(3024932) HLA-DR beta [Type]

122

742

1.64

6.42

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

410

3139

1.31

6.42

6.7

8.5

7.44

7.40

mmol/l

0.07

331

2603

(21494434) Karyotype in Bone marrow

307

2254

1.36

6.39

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

785

6488

1.21

6.37

1.2

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

343

1.95

6.27

1.2

1.3

—

(4211845) Urine protein measurement

188

1274

1.48

6.16

3.5

3.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

264

1905

1.39

6.13

1.5

1.4

12.43

12.94

u/l

0.66

254

1841

(3038071) Oxygen [Partial pressure] in Mixed venous blood

564

1.72

6.06

14.3

7.1

5.67

5.51

kpa

0.29

564

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

182

2.31

6.03

2.4

1.9

196.94

182.12

ug/g

0.16

156

(3016031) Almond IgE Ab [Units/volume] in Serum

195

2.26

6.00

1.0

1.1

0.40

1.08

u/ml

1.00

115

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

238

1697

1.40

5.95

1.0

37.68

42.07

ng/l

1.02

170

1192

(43055442) Apixaban [Mass/volume] in Serum or Plasma

436

1.81

5.91

1.5

1.6

101.02

110.80

ug/l

0.42

362

(3038177) Helicobacter pylori Ab [Presence] in Serum

535

4284

1.25

5.89

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

403

3119

1.29

5.86

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

540

1.72

5.86

1.3

1.20

1.18

mmol/l

1.37

540

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

237

1694

1.40

5.85

1.0

823.13

737.78

ng/l

1.54

160

1169

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

256

1854

1.38

5.84

1.1

19.49

19.48

u/ml

0.00

737

(3019768) Coxiella burnetii Ab [Presence] in Serum

148

2.43

5.82

1.1

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

469

1.77

5.75

1.3

76.75

408.22

titre

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

369

1.87

5.72

1.3

1.5

109096.94

189708.39

nmol/l

0.26

301

(3022493) Free Hemoglobin [Mass/volume] in Plasma

175

1190

1.47

5.67

6.0

3.9

127.68

1225.05

mg/l

1.89

133

853

(3020123) Porphyrins [Interpretation] in Serum or Plasma

144

2.43

5.66

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.53

5.58

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

145

953

1.52

5.55

2.7

0.61

mmol/l

0.41

145

953

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

171

2.28

5.49

1.0

1.1

5.44

10.04

u/l

1.73

171

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

166

1131

1.47

5.36

2.6

2.4

24.71

188.71

ug/l

1.75

160

1079

(3006576) Bicarbonate [Moles/volume] in Blood

125

804

1.56

5.30

6.7

6.6

25.40

24.86

mmol/l

0.84

111

729

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

185

1290

1.44

5.29

1.6

1.5

1695500.00

1979715.30

iu/ml

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

595

1.65

5.28

2.0

1.4

0.22

0.29

mmol/l

0.30

107

(3020491) Glucose [Moles/volume] in Blood

249

1830

1.36

5.24

1.6

1.8

7.34

6.67

mmol/l

2.22

179

1326

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

169

2.25

5.19

4.9

6.0

—

(37021550) Renin [Units/volume] in Plasma --upright

477

1.72

5.18

1.3

64.42

84.92

mu/l

0.47

346

(3013336) Amino acids [Identifier] in Serum or Plasma

2.75

5.17

1.6

2.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

202

2.13

5.15

1.7

1.4

—

(3049233) Organic acids panel - Urine

3.33

5.14

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

126

819

1.54

5.11

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

234

1714

1.37

5.05

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

120

774

1.55

5.05

1.2

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

342

1.84

5.03

1.0

83.00

79.24

ug/l

0.26

262

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

557

1.65

5.03

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

118

759

1.56

5.03

1.1

86.47

8.56

u/ml

0.57

442

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.16

5.02

1.3

1.4

223.85

120.19

nmol/l

1.19

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

231

1693

1.37

4.97

1.0

384.14

340.34

ng/l

0.29

165

1213

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

344

1.83

4.95

1.1

1.0

0.00

0.31

u/ml

1.47

216

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

403

1.76

4.91

6.5

7.0

10.78

10.46

0.55

403

(44813793) Dust mix specific IgE antibody measurement

260

1947

1.34

4.88

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

208

2.07

4.80

1.1

—

2.22

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

137

2.33

4.79

1.1

1.4

—

16893.89

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

125

2.40

4.77

1.6

1.2

1.10

1.52

0.24

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1824

20161

0.90

4.73

1.7

1.6

3.41

3.46

mmol/l

1.15

1248

13644

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

281

2140

1.31

4.70

1.9

1.8

4.21

3.78

mg/l

0.74

266

2046

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

458

3707

1.24

4.68

1.1

1.49

1.51

g/l

0.60

423

3385

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

149

1025

1.45

4.64

2.3

1.9

40.80

39.95

g/l

1.29

149

1025

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

267

2026

1.32

4.60

1.2

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

267

1.91

4.58

1.2

1.5

—

1.64

mmol/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.90

4.58

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

165

1161

1.42

4.56

1.1

8.44

9.71

u/ml

0.11

186

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

406

1.72

4.53

1.5

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.55

4.52

4.2

4.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

571

4746

1.21

4.51

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.15

4.46

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

522

1.63

4.45

1.1

19.00

5.95

u/ml

0.51

350

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

379

1.74

4.43

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

570

4746

1.20

4.42

1.2

1.1

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

150

2.20

4.33

2.1

1.3

17.71

12.24

0.46

107

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

550

1.60

4.30

1.2

365.76

295.64

pmol/l

0.79

390

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

361

1.74

4.27

1.1

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

145

2.21

4.24

1.2

1.1

46.33

58.84

u/l

0.44

117

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

102

2.45

4.19

4.6

95457.14

521867.50

u/ml

—

(3036180) Methadone [Presence] in Urine

3.41

4.17

2.5

2.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

127

2.28

4.17

13.5

11.4

229.96

240.00

e6/l

0.03

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

310

2436

1.27

4.14

1.4

8.13

8.54

mmol/l

1.21

285

2321

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

148

1042

1.42

4.12

1.1

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

180

2.05

4.12

1.0

0.20

0.21

u/ml

0.02

100

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

181

2.04

4.06

1.4

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

202

1.98

4.03

1.0

1.1

0.08

0.24

u/ml

1.02

202

(3038515) Glucose [Moles/volume] in Venous blood

630

5349

1.18

3.97

4.0

3.4

7.34

7.59

mmol/l

1.45

614

5226

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

386

1.68

3.91

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

227

1728

1.31

3.90

1.1

1.16

2.57

u/ml

1.42

617

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

654

5580

1.17

3.89

2.9

3.5

266.85

992.93

u/ml

2.57

589

5048

(40765096) Chromosome analysis panel by Banding

111

751

1.48

3.84

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

543

1.57

3.84

1.0

1.1

35.29

29.69

iu/ml

0.37

543

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

264

2056

1.29

3.83

1.5

1.4

—

(3045142) Bone marrow Pathology biopsy report

364

2946

1.24

3.81

1.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

383

1.67

3.76

1.5

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

204

1539

1.33

3.75

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.73

3.73

2.0

2.1

264.00

238.16

ug/l

0.21

(3017461) Flecainide [Moles/volume] in Serum or Plasma

147

2.11

3.71

1.5

1.8

0.81

0.72

umol/l

0.36

109

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

202

1524

1.33

3.71

1.5

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.64

3.71

5.6

6.9

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

267

1.80

3.65

1.0

5.12

0.42

u/ml

0.48

124

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

379

1.66

3.64

2.5

2.3

1.23

1.42

mmol/l

0.32

263

(3052592) Norovirus Ag [Presence] in Stool

480

1.58

3.62

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

189

1421

1.33

3.58

2.0

8.13

mmol/l

0.00

189

1421

(3006571) Granulocytes/Leukocytes in Synovial fluid

390

3203

1.22

3.57

1.5

1.6

57.58

57.66

0.01

228

2009

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

104

2.31

3.57

1.3

1.5

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

7.77

3.55

1.0

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.50

3.52

2.9

1.3

77.62

137.75

ug/l

1.48

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

659

5681

1.16

3.49

2.3

2.4

118.77

110.81

ug/min

0.16

382

3349

(3010370) Gastrin [Moles/volume] in Serum or Plasma

431

1.60

3.46

1.3

2.0

66.66

48.24

pmol/l

0.53

363

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

173

1.96

3.40

1.2

47.69

44.84

mg/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

133

2.10

3.37

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

189

1437

1.32

3.34

1.8

2.3

16.07

15.82

0.47

189

1437

(3011841) English Walnut IgE Ab [Units/volume] in Serum

290

1.72

3.33

1.0

1.1

1.05

4.33

u/ml

1.82

229

(3036312) Salmon IgE Ab [Units/volume] in Serum

161

1.99

3.31

1.0

1.1

0.10

2.54

u/ml

1.80

117

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

108

2.22

3.29

10.3

9.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

516

1.53

3.29

1.3

1.2

123.41

47.65

mg/l

0.50

369

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1591

14529

1.10

3.28

3.2

3.6

43.84

58.45

u/ml

1.42

1529

14039

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1079

9659

1.12

3.26

3.0

3.5

647.57

1473.33

u/ml

1.29

921

8322

(3010144) Erythrocytes [#/volume] in Synovial fluid

305

2471

1.24

3.23

1.5

1.4

141981.60

138771.03

e6/l

0.03

196

1647

(3007542) Rye IgE Ab [Units/volume] in Serum

143

2.03

3.18

1.0

0.06

0.49

u/ml

1.17

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

6.36

3.18

1.0

1.1

21.29

21.45

umol/l

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

200

1545

1.29

3.17

1.2

1.1

24.76

23.18

u/l

0.10

182

1369

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

296

1.69

3.12

1.0

0.07

2.29

u/ml

0.91

138

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

290

1.69

3.07

1.0

0.03

0.82

u/ml

1.78

139

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

191

1474

1.30

3.06

21.0

20.3

1338.79

2054.58

nmol/l

0.57

181

1419

(40762887) Creatinine [Moles/volume] in Blood

188

1.86

3.03

1.5

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

167

1.91

3.02

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.33

3.00

1.4

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

392

3287

1.19

2.97

1.8

2.0

17.32

25.66

ug/l

6.43

380

3211

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

603

6910

0.87

2.95

1.5

1.12

1.19

ratio

1.15

360

4189

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

603

6910

0.87

2.95

1.5

0.95

0.94

ratio

0.19

358

4157

(4034850) Laboratory test

879

7827

1.13

2.95

11.7

10.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

530

1.49

2.94

6.8

6.5

70.25

69.48

0.09

403

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

234

1.75

2.93

1.2

1.4

14.63

15.66

nmol/l

0.21

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

199

1555

1.28

2.92

1.2

1.1

84.25

82.35

u/l

0.10

179

1383

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

592

6783

0.87

2.90

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

210

1654

1.27

2.89

1.2

1.1

2.89

6.46

u/ml

0.66

463

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

690

6063

1.14

2.87

1.4

126.92

151.72

pmol/l

0.89

670

5911

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

602

6883

0.87

2.86

1.5

1.15

1.16

ratio

0.13

357

4131

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.43

2.86

1.0

1.1

0.20

0.21

g/l

0.44

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

207

1631

1.27

2.85

1.6

1.5

6.20

7.01

u/l

0.45

172

1295

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

171

1.87

2.83

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

188

1467

1.28

2.80

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.76

2.80

1.2

1.4

1.71

2.01

g/l

0.40

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

670

1.42

2.76

1.3

1.2

9.30

12.99

pmol/l

0.90

242

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

309

2558

1.21

2.72

1.3

—

titre

—

(3005011) Chlamydia sp Ab [Titer] in Serum

356

1.57

2.69

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

370

3119

1.19

2.68

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

152

1163

1.31

2.65

2.1

83.32

105.08

ug/min

0.19

258

(3044009) aPTT.lupus sensitive (LA screen)

212

1.74

2.64

1.2

—

(3047189) Immunofixation for 24 hour Urine

152

1164

1.31

2.64

2.0

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1201

13128

0.91

2.64

1.6

964.40

1006.03

mu/l

0.68

1025

11166

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

172

1340

1.28

2.62

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

172

1340

1.28

2.62

1.3

1.6

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

536

1.45

2.62

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

352

2962

1.19

2.61

2.7

2.3

105.93

105.52

mmol/l

1.02

347

2942

(3047352) Trisomy 18 risk [Likelihood] in Fetus

490

5638

0.87

2.59

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

206

1645

1.25

2.57

1.5

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

909

8183

1.11

2.57

1.4

1.5

—

(40759632) Porphyrins [Mass/mass] in Stool

4.00

2.56

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

135

1.92

2.53

35.4

7.4

105.42

103.86

g/l

0.17

135

(3035320) C reactive protein [Mass/volume] in Body fluid

263

2161

1.22

2.53

3.3

2.6

26.94

28.39

mg/l

0.24

184

1565

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

355

1.55

2.50

1.4

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

246

1.67

2.50

1.0

0.19

1.61

u/ml

1.86

174

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

158

1229

1.29

2.46

4.7

3.9

—

(3002619) Bacteria identified in Specimen by Culture

720

1.37

2.45

1.2

1.3

—

(3005033) Fetal Nuchal fold Thickness US

482

5526

0.87

2.44

1.5

1.27

1.26

0.24

344

4059

(3033942) Copper [Moles/time] in 24 hour Urine

109

2.02

2.44

1.6

1.2

0.48

0.84

umol/24h

0.41

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

195

1.74

2.44

1.1

12.33

28.91

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

302

1.59

2.44

1.0

1.1

3.27

2.95

u/ml

0.06

238

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

204

1.71

2.38

2.0

1.6

—

(3041184) Isoniazid [Presence] in Urine

3.33

2.38

2.8

2.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

289

2413

1.20

2.37

1.2

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

227

1.67

2.37

1.1

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

6.24

2.37

5.4

2.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

197

1.72

2.37

1.4

1.5

22.28

15.11

pmol/l

0.39

172

(3023199) Leukocytes [#/volume] in Pleural fluid

379

3244

1.17

2.34

1.5

1766.10

3300.17

e6/l

2.14

262

2272

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

130

994

1.31

2.33

1.2

1100.00

992.46

titre

0.50

199

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

314

1.56

2.32

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

719

1.36

2.32

1.7

1.9

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

176

1400

1.26

2.31

15.9

15.0

766.93

1740.74

nmol/l

0.54

168

1354

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

468

1.45

2.31

2.0

1.6

0.25

0.23

nmol/l

0.16

334

(3017400) Magnesium [Moles/volume] in Urine

2.31

2.30

1.4

1.1

3.42

2.91

mmol/l

0.42

(3043238) Trisomy 21 risk [Likelihood] in Fetus

506

5753

0.88

2.29

1.5

1.6

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

192

1.72

2.28

3.5

3.6

8.32

9.14

0.07

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

111

833

1.33

2.27

1.3

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

127

1.89

2.24

1.0

1.1

0.05

0.62

u/ml

1.41

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

422

1.47

2.24

2.3

2.7

54.26

45.13

mg/l

0.13

103

(3015076) Soybean IgE Ab [Units/volume] in Serum

186

1497

1.24

2.22

1.1

0.46

1.17

u/ml

0.96

404

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

209

1.67

2.21

1.5

1.3

1.17

1.60

ml/s/173m2

0.51

139

(3032641) Amino acids panel - Urine

2.68

2.20

1.1

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

2.12

2.17

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

338

2890

1.17

2.15

1.4

1.5

48809.86

55672.24

e6/l

0.23

185

1622

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.00

2.14

1.1

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

2.16

2.13

1.5

2.6

1.32

0.14

ug/l

0.98

(3012565) Volume of 24 hour Urine

160

1273

1.26

2.13

2.0

2.2

1916.94

1936.11

0.10

144

1126

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

653

7270

0.89

2.12

1.5

62.68

62.17

ug/l

0.10

536

6104

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

111

843

1.32

2.12

2.6

2.9

99.33

151.90

au/ml

0.64

126

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

146

1834

0.79

2.08

1.6

1.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.90

2.06

1.1

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

276

1.56

2.06

1.0

0.22

0.27

u/ml

0.07

164

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

206

1.65

2.05

2.9

29.75

61.06

pmol/l

0.48

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

147

1165

1.26

2.04

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

194

1586

1.22

2.04

1.5

1.3

159.35

174.39

pmol/l

0.85

194

1586

(3001556) Androgen free Index in Serum or Plasma

231

1.60

2.00

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

185

1.67

1.99

1.0

6.60

1.33

u/ml

0.59

148

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

116

898

1.29

1.95

1.9

2.2

8.92

9.20

mg/l

0.21

749

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.98

1.94

1.1

0.05

0.04

u/ml

0.32

(3008896) Cortisol [Moles/volume] in Urine

4.54

1.94

1.2

1.0

339.20

85.64

nmol/l

—

(3003577) Lead [Moles/volume] in Blood

204

1.62

1.87

1.2

1.4

0.45

0.19

umol/l

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.85

1.85

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

191

1577

1.21

1.85

6.8

7.2

19.89

83.36

ug/l

1.91

121

1043

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

382

1.44

1.85

1.4

1.2

33.07

42.13

mg/l

0.99

323

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

263

2236

1.18

1.84

1.9

1.8

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

2.20

1.83

1.8

1.3

1.54

10.05

mg/l

1.93

(40762814) Titanium [Mass/volume] in Blood

408

1.42

1.82

2.1

2.5

2.99

3.76

ug/l

1.01

163

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

165

1345

1.23

1.82

1.7

2.3

194.34

201.34

u/l

1.05

165

1332

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

120

944

1.27

1.81

3.7

8.41

8.58

mg/l

0.10

104

758

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.00

1.79

1.0

0.03

0.09

u/ml

1.22

(3025549) Creatine [Moles/time] in 24 hour Urine

199

1.61

1.78

1.2

1.4

—

14.25

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

484

5415

0.89

1.78

4.1

3.4

23.16

27.30

mg/l

2.06

309

3781

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

675

1.32

1.77

1.7

1.8

100.19

133.04

au/ml

0.35

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

336

1.46

1.77

2.5

2.9

51.49

75.64

pmol/l

1.20

294

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

327

3750

0.87

1.77

1.2

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

161

1.68

1.76

1.0

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

177

1.64

1.74

1.1

1.0

6.46

0.62

u/ml

0.44

164

(3020356) Listeria sp identified in Specimen by Organism specific culture

162

1.67

1.73

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

2.22

1.73

1.0

—

1.07

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.29

1.69

3.5

4.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

234

1.54

1.68

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

302

2619

1.15

1.67

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

291

1.48

1.67

1.1

293.57

281.93

u/ml

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

187

1.60

1.67

2.1

2.4

0.57

0.69

ug/l

1.67

187

(3003434) Protein [Mass/volume] in Pleural fluid

412

3654

1.13

1.64

1.4

1.5

31.64

32.82

g/l

1.20

374

3321

(3019174) dRVVT (LA screen)

212

1.56

1.63

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

409

4593

0.89

1.63

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

524

0.67

1.63

1.1

1.2

76.74

70.64

ug/l

0.26

524

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

205

1732

1.18

1.60

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

278

1.47

1.59

1.4

1.2

6.11

6.53

mmol/l

0.21

128

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

412

3662

1.13

1.59

2.6

2.8

293.03

666.42

u/ml

0.64

405

3620

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

361

1.41

1.59

4.6

5.4

62.53

42.48

ug/min

0.73

278

(40761539) Cells [Type] in Urine sediment by Light microscopy

635

1.31

1.59

1.1

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.06

1.59

1.0

0.17

0.05

u/ml

0.36

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

3.00

1.58

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

102

804

1.27

1.56

1.4

1.3

43.18

39.46

g/l

2.39

409

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

490

1.35

1.55

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

491

1.34

1.54

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

491

1.34

1.54

1.3

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.97

1.53

1.1

1.2

29.03

51.31

umol/24h

0.54

(3017509) Phencyclidine [Presence] in Urine

282

1.45

1.50

2.6

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

434

1.36

1.49

1.4

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

503

1.33

1.48

2.0

2.3

8.38

7.36

mmol/l

0.53

309

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

116

1.72

1.47

1.2

1.0

0.02

0.10

u/ml

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

366

0.63

1.45

1.0

7.76

10.81

u/ml

0.34

366

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.87

1.43

1.1

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.12

1.43

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.97

1.42

5.8

8.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

128

1051

1.22

1.39

1.3

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.07

1.38

1.1

1.0

—

(3022475) Manganese [Moles/volume] in Blood

142

1.62

1.37

1.3

0.15

0.16

umol/l

0.56

142

(3006567) Chloride [Moles/time] in 24 hour Urine

2.19

1.36

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

223

1.48

1.34

1.1

97.94

93.99

titre

0.11

223

(3007463) Buprenorphine [Presence] in Urine

105

1.71

1.32

7.2

5.7

—

(3000285) Sodium [Moles/volume] in Blood

496

1.31

1.32

1.3

1.2

137.64

138.24

mmol/l

0.45

421

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

250

1.44

1.29

1.1

0.24

0.67

u/ml

1.71

123

(40763480) Human metapneumovirus Ag [Presence] in Specimen

129

1.63

1.29

1.7

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

118

971

1.21

1.28

2.0

1.9

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.77

1.28

1.0

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.82

1.24

1.0

1.1

—

(4212803) Bone marrow aspirate examination

211

1.47

1.24

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

600

1.27

1.21

1.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

124

1.61

1.19

1.4

1.3

1.31

1.79

mg/l

1.18

102

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.31

1.18

2.2

2.5

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.93

1.16

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

231

1.43

1.16

1.5

1.3

7.21

15.65

pmol/l

1.98

193

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

569

1.26

1.15

2.1

2.6

88.10

410.94

ug/l

0.82

569

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

282

2511

1.12

1.15

1.3

372.33

500.45

u/l

0.71

264

2382

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

2.50

1.15

1.2

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.68

1.13

1.1

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.68

1.13

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

106

877

1.21

1.13

1.1

1.0

9.18

10.40

u/ml

0.21

556

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

103

1.65

1.12

1.1

280.82

268.21

nmol/l

0.09

103

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

208

1.44

1.11

1.1

1.0

—

(3000012) Reticulocyte production index

420

3828

1.10

1.11

2.0

2.2

0.94

0.90

0.82

291

2588

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

327

1.34

1.10

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

143

1.54

1.10

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

104

1.63

1.08

1.2

1.0

0.02

0.05

u/ml

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

104

1.63

1.08

1.0

1.1

0.21

1.68

u/ml

1.20

104

(4133840) Spirometry

646

1.24

1.08

1.3

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.95

1.08

1.0

0.01

0.83

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

277

1.37

1.08

2.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.76

1.06

1.2

1.0

5.51

15.25

mg/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

980

9248

1.06

1.05

1.5

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

203

1.43

1.04

3.3

2.9

—

(3020393) Adenovirus Ag [Presence] in Stool

349

1.32

1.02

1.8

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.63

1.02

1.1

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

306

1.34

1.02

1.3

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.91

1.02

1.4

1.5

500.89

394.87

mg/24h

—

(3000034) Microalbumin [Mass/volume] in Urine

242

2159

1.12

0.99

3.1

3.0

55.19

49.09

mg/l

0.15

165

1547

(3035880) pH of Pleural fluid

157

1363

1.15

0.98

1.2

1.3

7.42

7.41

0.44

119

954

(1617658) Protocol used for examination of sentinel lymph nodes

173

1970

0.88

0.98

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

435

0.73

0.97

4.9

5.7

9.31

8.56

mmol/l

0.80

435

(3025577) Chromium [Mass/volume] in Blood

166

1450

1.14

0.96

2.1

2.2

2.72

2.31

ug/l

0.36

136

1204

(4281824) Cell count and differential, peritoneal fluid

271

2997

0.90

0.95

1.2

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.89

0.94

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.65

0.93

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

133

1.50

0.93

1.6

1.5

476.21

531.82

nmol/l

0.20

133

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

208

1.39

0.93

1.0

1.1

17.83

17.18

iu/ml

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

159

1.45

0.90

1.3

1.6

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.07

0.89

1.0

0.03

0.07

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

132

1143

1.15

0.88

1.8

2.69

2.66

u/ml

0.01

320

(40768441) Liver Pathology biopsy report

220

1971

1.12

0.87

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.78

0.87

1.0

1.1

4.00

2.75

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

403

4353

0.92

0.87

3.8

29.48

39.95

u/ml

1.50

393

4209

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

144

1.46

0.86

1.1

1.2

1.42

1.12

u/field

0.39

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

154

1352

1.14

0.85

1.4

5.68

mmol/l

0.01

148

1273

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

136

1.47

0.85

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

238

1.34

0.85

2.1

1.7

44.13

48.49

umol/l

0.38

238

(40757373) Influenza virus identified in Isolate

477

1.24

0.84

1.5

1.6

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

1.93

0.84

1.2

1.0

2.38

8.38

u/ml

—

(3032868) Hemoglobin electrophoresis panel in Blood

230

1.35

0.83

1.6

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

156

1375

1.13

0.82

1.6

1.9

1.70

2.70

u/field

2.16

112

962

(3034891) Synovial lining cells/cells in Synovial fluid

145

1272

1.14

0.82

1.3

1.5

4.61

3.67

0.25

270

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

689

1.19

0.81

1.5

1.7

10.21

9.29

ug/l

0.86

689

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.64

0.81

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.70

0.80

1.3

1.6

1.98

1.95

mmol/24h

—

(3026470) Cobalt [Mass/volume] in Blood

168

1495

1.12

0.78

2.1

2.2

3.98

3.64

ug/l

0.15

154

1386

(3013945) Hepatitis B virus e Ab [Presence] in Serum

148

1.42

0.77

1.3

1.5

—

(40768806) Pleura Pathology biopsy report

298

2734

1.09

0.77

1.4

1.5

—

(3024263) Appearance of Synovial fluid

145

1281

1.13

0.76

1.4

1.7

—

(3004775) Volume in Urine collected for unspecified duration

171

1907

0.90

0.75

2.4

2.3

676.47

661.57

0.18

117

1307

(3042010) Triglyceride [Moles/volume] in Pleural fluid

423

0.78

0.72

1.4

1.2

0.74

1.45

mmol/l

1.10

281

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.52

0.71

1.1

1.20

1.31

u/field

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.58

0.71

1.0

1.2

—

mmol/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

255

1.29

0.70

3.3

3.4

—

(3001729) Color of Synovial fluid

193

0.67

0.69

1.2

1.7

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

100

869

1.15

0.69

1.4

63.95

63.30

0.07

716

(3036782) Glucose [Moles/volume] in Pleural fluid

281

2595

1.08

0.65

1.3

6.51

6.30

mmol/l

0.75

269

2413

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

285

1.26

0.65

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

660

1.17

0.64

1.5

1.3

40.09

38.44

0.13

446

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.61

0.64

1.0

—

(3016750) Collection duration of Urine

125

1402

0.89

0.64

2.3

2.2

507.32

500.26

min

0.41

1052

(3022670) pH of Venous cord blood

1.55

0.61

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

105

926

1.13

0.61

2.2

2.5

146.22

146.26

nmol/l

0.00

813

(40761536) Microorganisms panel - Urine sediment

2207

21508

1.03

0.59

5.1

4.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

245

1.26

0.59

1.1

1.2

79.40

105.02

ug/l

0.73

154

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

107

1.40

0.55

1.6

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

129

1165

1.11

0.53

1.1

1.2

10.06

10.30

mm/h

0.10

129

1165

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.43

0.52

1.4

1.0

301.33

203.71

pmol/l

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.51

0.52

5.7

1.5

1216.00

1256.13

umol/l

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

152

1.31

0.51

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

161

1.30

0.51

2.0

1.4

318.86

327.29

umol/24h

0.06

161

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

224

1.25

0.50

2.6

2.0

67.26

59.45

0.56

143

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

189

1.27

0.49

2.0

1.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

223

0.76

0.48

1.0

1.1

1.14

1.21

mom

0.17

223

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.49

0.47

1.0

1.1

—

371.20

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

190

1.26

0.47

2.4

2.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

281

1.21

0.46

1.2

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

569

1.14

0.46

1.3

1.4

21.38

23.03

0.19

478

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

1.43

0.46

1.4

1.3

1.92

2.70

mmol/l

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

138

1.30

0.45

2.9

3.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

226

2112

1.07

0.45

1.7

2.1

2.37

2.93

u/field

0.20

130

1159

(3026726) Creatinine [Moles/volume] in Specimen

210

1.24

0.44

3.2

2.3

199.00

360.52

umol/l

1.13

202

(3041918) Cholesterol [Moles/volume] in Pleural fluid

523

0.86

0.44

1.3

1.2

1.81

1.59

mmol/l

0.43

325

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.45

0.44

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

658

1.12

0.42

2.9

148.24

111.74

ng/l

0.81

365

(3003329) Lymphocytes/Leukocytes in Synovial fluid

256

2409

1.06

0.42

1.4

1.5

27.07

31.29

1.06

133

1477

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

167

1.26

0.41

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

133

1225

1.08

0.40

5.4

6.0

1112.59

4111.95

u/ml

0.42

195

(3002331) Protein [Mass/volume] in Peritoneal fluid

624

0.88

0.40

1.5

1.4

24.22

38.12

g/l

0.79

482

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

132

1.29

0.40

1.1

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

343

1.17

0.39

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

288

1.18

0.38

1.2

6.01

5.90

mmol/l

0.29

288

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.39

0.38

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.30

0.37

1.0

6.78

3.87

u/ml

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

482

0.87

0.37

3.2

3.3

46.21

44.21

0.31

482

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

503

0.87

0.36

2.1

1.9

2.09

2.89

ug/l

0.62

318

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

271

1.18

0.36

3.3

3.0

1.78

1.24

mg/l

0.77

197

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

182

1937

0.94

0.36

1.5

1.6

8.16

7.74

mmol/l

1.82

177

1862

(3044416) Complement C4 [Mass/volume] in Pleural fluid

125

1.28

0.36

1.5

1.2

0.07

g/l

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

481

0.87

0.36

6.3

6.6

7.88

8.85

0.68

481

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

396

3795

1.04

0.35

1.5

1.4

3.04

3.87

ug/l

1.51

350

3374

(3001019) Free T4 and TSH panel - Serum or Plasma

1261

12319

1.02

0.34

1.6

1.7

—

(42870560) Thyrotropin [Units/volume] in Cord blood

265

0.83

0.34

1.0

10.08

8.81

mu/l

0.55

220

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

201

1.19

0.32

1.0

1.1

3.79

8.15

u/ml

—

121

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

852

0.91

0.32

2.0

1.8

5991.76

11988.24

e6/l

0.84

432

(40765089) Chromosome analysis panel - Blood by G-banded

846

1.09

0.31

1.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

370

1.13

0.31

1.4

1.5

7.63

12.68

0.91

193

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

343

1.14

0.30

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

175

1.20

0.29

3.8

5.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

208

1977

1.05

0.29

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

129

0.77

0.28

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

614

6296

0.97

0.26

5.1

4.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

985

0.93

0.25

2.0

10052.27

1649.44

e6/l

0.51

646

(3050129) First trimester maternal screen panel - Serum or Plasma

848

8648

0.98

0.24

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

158

0.82

0.23

1.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

284

2737

1.04

0.23

3.9

4.1

39.55

58.88

u/ml

1.04

278

2703

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.31

0.23

1.2

1.1

1656.00

1807.89

titre

—

(40760410) HLA-B [Type] by High resolution

0.75

0.22

1.0

—

(40760409) HLA-A [Type] by High resolution

0.75

0.22

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

457

1.09

0.22

1.6

1.8

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

671

1.07

0.21

1.4

21.77

20.62

0.15

604

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

182

1.15

0.21

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

831

0.94

0.20

2.2

1.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

206

1982

1.04

0.20

1.2

1.3

12.42

14.31

u/l

0.69

185

1827

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.18

0.19

2.0

2.1

24.40

29.76

—

(3020650) Glucose [Presence] in Urine

930

0.94

0.19

2.0

1.6

0.03

0.04

estimate

0.07

930

(3016273) Islet cell 512 Ab [Units/volume] in Serum

196

0.87

0.18

1.1

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

143

0.84

0.18

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

130

1357

0.96

0.18

1.9

1.8

125.10

716.17

pmol/l

0.71

192

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

618

6288

0.98

0.17

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

252

1.11

0.17

1.4

1.2

0.53

0.39

u/ml

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

176

1.14

0.17

1.1

1.0

—

(40758292) HTLV I+II Ab panel - Serum

476

1.07

0.15

1.3

—

(44806420) Estimation of glomerular filtration rate

277

2837

0.97

0.15

2.4

2.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

758

0.95

0.15

1.2

1.3

242.05

296.95

ug/l

0.15

404

(3023383) Lactate [Moles/volume] in Pleural fluid

791

1.05

0.14

1.3

3.35

3.48

mmol/l

0.14

728

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

362

1.08

0.14

1.4

1.2

185.52

235.33

u/l

0.12

260

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

179

1.12

0.14

3.1

2.0

13.45

18.74

0.39

(3021162) Amylase [Enzymatic activity/volume] in Specimen

442

1.06

0.12

3.0

2.7

800.49

1627.46

u/l

0.72

400

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

477

4838

0.98

0.12

1.5

59.23

60.67

ug/l

0.29

477

4838

(3018834) Bilirubin.total [Presence] in Urine by Test strip

133

1.13

0.11

2.1

3.8

—

0.00

estimate

—

(3029612) Listeria sp Ab [Titer] in Serum

1.14

0.10

1.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

125

1.12

0.10

1.3

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

706

0.96

0.09

1.3

1.4

12.81

13.61

g/l

0.31

536

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

1.04

0.09

1.0

1.4

0.20

0.36

—

(3003157) Bacteria [#/volume] in Mother's milk

1.09

0.08

4.2

7.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

334

3382

0.99

0.08

1.3

7.23

7.19

mmol/l

0.09

302

2960

(40763791) Oxygen content in Venous blood by calculation

0.82

0.07

6.8

6.4

11.57

12.21

ml/dl

—

(3022725) Serotonin [Moles/volume] in Serum

1.12

0.07

1.5

734.82

890.65

nmol/l

0.32

(40763590) HLA-DQ beta [Type]

0.87

0.06

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.86

0.06

1.0

—

(40768795) Lymph node Pathology biopsy report

264

2671

0.99

0.06

1.3

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

305

1.05

0.06

2.1

2.6

0.84

0.58

u/field

0.62

305

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

158

1.07

0.06

1.0

5.26

17.65

u/ml

2.26

130

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

356

1.04

0.05

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

110

1.09

0.05

1.2

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

743

1.02

0.04

1.5

1.4

2.76

2.85

0.04

629

(3005082) Progesterone [Moles/volume] in Serum or Plasma

147

1448

1.01

0.04

1.6

1.5

35.75

35.02

nmol/l

0.09

133

1327

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

122

1234

0.99

0.03

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

101

995

1.01

0.03

1.7

1.6

3878.10

3365.85

titre

0.27

164

(3014891) Appearance of Pleural fluid

331

1.03

0.02

1.6

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

969

0.99

0.02

1.7

1.4

0.53

0.51

e9/l

0.39

969

(3006598) pH of Arterial cord blood

232

1.03

0.02

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

232

1.03

0.02

1.0

-4.90

-2.10

mmol/l

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

720

1.01

0.01

1.4

57.43

55.04

0.23

614

(4038314) Semen analysis, post vasectomy

143

1.05

0.01

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

115

1140

1.01

0.01

3.3

1.34

1.26

0.24

115

1140

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

286

0.98

0.01

1.4

72.66

72.49

0.01

238

(46235168) Fasting glucose [Moles/volume] in Blood

306

0.98

0.01

1.2

2.1

7.62

7.61

mmol/l

0.00

108

(40758358) Immune stain study

114

0.96

0.00

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

288

1.01

0.00

1.1

19.96

20.84

u/l

0.13

188

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

107

1.03

0.00

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

353

0.99

0.00

1.1

1.2

20.63

20.53

mmol/l

0.05

298

(3029396) Erythrocyte agglutination [Presence] in Blood

780

1.00

0.00

2.7

3.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.00

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

2.44

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.92

-0.00

1.0

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

7.87

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.9

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.96

-0.00

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.01

-0.00

1.0

1.2

38.73

30.76

mg/24h

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.89

-0.00

7.4

5.7

0.19

0.22

mmol/l

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

346.83

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.96

-0.00

1.6

1.1

158.00

276.20

u/ml

—

(3013762) Body weight Measured

1.02

-0.00

1.3

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: H7_VISUALDISTBLIND – Visual disturbances and blindness

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Visual disturbances and blindness

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Visual disturbances and blindness (H7_VISUALDISTBLIND)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints